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Abstract
Evidence-based treatments for post-traumatic stress disorder (PTSD) improve overall
symptoms, but sleep disturbance often persists. Insomnia and obstructive sleep apnea (OSA)
frequently co-occur with PTSD and contribute to the overall sleep disturbance. Successfully
treating the sleep disturbance that occurs in the context of PTSD, including insomnia and OSA
when present, will improve sleep, decrease PTSD symptoms, and enhance quality of life. This
DNP project adapted an assessment and treatment protocol for Veterans with PTSD and sleep
disturbance for use in an outpatient Veterans Affairs (VA) PTSD clinic. The protocol was
implemented in a patient education and treatment-planning group for Veterans with PTSD.
Screening measures for insomnia and OSA were distributed to group participants. The group
curriculum and patient education materials were revised to include information about insomnia,
OSA and their treatments. Eight Veterans attended the group during the implementation period
and were sent the Insomnia Severity Index and STOP Questionnaire. Two veterans returned the
questionnaires: both screened positive for insomnia and one screened positive for OSA. One
referral to Cognitive Behavioral Therapy for Insomnia was submitted following the group.
Results suggest that screening for insomnia and OSA in an outpatient VA PTSD clinic will
uncover high rates of co-morbidity. A longer implementation period and larger sample size are
needed to determine if these methods will increase referrals to evidence-based treatments
recommended by the protocol. The protocol offers a strategy for treating Veterans with PTSD
and sleep disturbance that supports measurement-based care, evidenced-based practice, and drug
safety initiatives.
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Glossary of Abbreviations

AA-Auricular Acupuncture
APAP-Advanced Positive Airway Pressure
CBT-I-Cognitive Behavioral Therapy for Insomnia
CPAP-Continuous Positive Airway Pressure
CPT-Cognitive Processing Therapy
DSM-5-Diagnostic and Statistical Manual of Mental Disorders
EBP-Evidenced-Based Psychotherapy
EMR-Electronic Medical Record
ERRT-Exposure, Rescripting, and Relaxation Therapy
ISI-Insomnia Severity Index
IRT-Imagery Rehearsal Therapy
MAD-Mandibular Advancement Device
MBC-Measurement Based Care
MHTC-Mental Health Treatment Coordinator
MRP-Mantram Repetition Program
OEF-Operation Enduring Freedom
OIF-Operation Iraqi Freedom
OSA-Obstructive Sleep Apnea
PE-Prolonged Exposure
PTSD-Post-traumatic stress disorder
SIP-Sleep Intervention for PTSD
TREC-Trauma Recovery and Education Class
VA-Veterans Affairs
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Chapter 1: Introduction
Post-traumatic stress disorder (PTSD) is a mental health condition that can develop after
an individual experiences a traumatic event. The Diagnostic and Statistical Manual of Mental
Disorders (5th ed.; DSM–5; American Psychiatric Association, 2013) categorizes the symptoms
of PTSD in four clusters which include re-experiencing, hyperarousal, avoidance, and changes in
thoughts and mood. Although poor sleep is known as a hallmark of the disorder, “sleep
disturbance” accounts for just one of the twenty symptoms of PTSD listed in DSM-5.
Historically, sleep disturbance in the presence of PTSD was thought to occur as an effect of the
development of PTSD and associated symptom profile. More recent studies have suggested that
sleep disturbance may play a causal role in the development of PTSD or be an early indicator of
PTSD in the aftermath of trauma (Akkinui & Solh, 2019; Koren et al., 2002).
A diagnosis of PTSD alone often does not capture the severity or complexity of sleep
disturbance that patients with this condition experience. Often, DSM-5 criteria for insomnia are
also met, and this additional diagnosis is warranted. Further, a developing area of research finds
that obstructive sleep apnea (OSA), a condition marked by disrupted breathing during sleep, is
more common when PTSD is present (Zhang et al., 2017). OSA may play a role in the
development and maintenance of sleep disturbance in some patients with PTSD, and account for
a significant portion of the sleep problems reported (El-Solh et al., 2018). Several hypotheses
regarding this common co-morbidity have been suggested, and this remains an active area of
research (Jaoude et al., 2015; Krakow et al., 2000; Kinoshita et al., 2012).
Problem Statement
The estimated prevalence of PTSD in the general population is 8% (National Center for
PTSD). Among Veterans, rates are higher, and vary based on era of military service. The
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estimated prevalence of PTSD among Vietnam era Veterans is 30.9% for men and 26.9% for
women (Kulka et al., 1990), while the prevalence of PTSD among Operation Enduring Freedom
(OEF) and Operation Iraqi Freedom (OIF) service members is 13.8% (Tanielian & Jaycox,
2008). Sleep complaints are common in individuals with PTSD; sleep disturbance was reported
in over 90% of Vietnam era Veterans with PTSD (Neylan et al.,1998; Lewis et al., 2009).
Active-duty service members with PTSD report much higher rates of insomnia (92%) than their
counterparts without PTSD (28%) (Seelig et al., 2010). Rates of co-occurring PTSD and sleep
disturbance vary based on how sleep disturbance is assessed; when the DSM criteria for
insomnia is used, the range is 31-65% (Colvonen et al., 2018). The co-occurrence of PTSD and
OSA is also common, with one meta-analysis reporting an aggregate prevalence rate of 63%
among individuals with PTSD compared with 7% in individuals without PTSD (Zhang et al.,
2017). Prevalence data about the multi-morbidity of PTSD, insomnia and OSA is limited,
however, in one study of crime victims with nightmares and insomnia, almost half had evidence
of OSA (Krakow et al., 2001).
Veterans with PTSD experience a high symptom burden. Evidence-based treatments for
PTSD can reduce symptoms and improve functioning, however, sleep disturbance often persists
(Belville et al., 2011; Gutner et al., 2013; Pruiksma et al., 2016; Zayfert & DeViva, 2004).
Insomnia and OSA, when present, contribute to the overall sleep disturbance and complicate
treatment. These co-morbidities can be overlooked, as their symptoms overlap with PTSD.
Successfully treating the sleep disturbance that occurs in the context of PTSD, including
insomnia and OSA when present, will improve sleep, decrease PTSD symptoms, and enhance
overall quality of life. This DNP Quality Improvement project adapted an assessment and
treatment protocol for Veterans with PTSD and sleep disturbance for an outpatient Veterans
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Affairs (VA) PTSD clinic, and implemented the protocol in a patient education and treatmentplanning group to increase referrals to evidence-based treatments recommended by the protocol.
Significance
Sleep disturbance and insomnia have been associated with a variety of negative
consequences including worsening suicidal ideation (Nadorff et al., 2011), increased alcohol use
(Nishith et al., 2001), and cognitive deficits (Martindale et al., 2016). In a military cohort,
insomnia was associated with poor “self-rated health,” increased healthcare utilization, and lost
workdays (Seelig et al., 2016). In the context of PTSD, a night of poor sleep was associated with
increased PTSD symptoms and negative affect the following day (Short et al., 2017). Further,
evidence suggests that insomnia may interfere with neurobiological mechanisms needed for
successful PTSD therapy, rendering the treatments themselves less effective (Colvonen et al.,
2019).
Individuals with PTSD and OSA present with more severe PTSD symptoms and sleep
disturbance than those with PTSD alone (Krakow et al., 2002). When OSA and PTSD co-occur,
quality of life, functioning, and fatigue are worse than in either condition alone (Lettieri et al.,
2016). OSA severity has been positively correlated with increased reports of suicidal ideation in
civilians with PTSD (Gupta & Jarosz, 2018). Veterans with the multi-morbidity of PTSD,
insomnia, and OSA have worse sleep, depression, and overall quality of life than Veterans with
PTSD and OSA (El-Solh et al. 2018). Treatment challenges in patients with co-occurring PTSD
and OSA are bi-directional. As with insomnia, untreated OSA appears to be associated with
decreased effectiveness of PTSD treatment (Mesa et al., 2017; Reist et al., 2017). Conversely,
both insomnia and PTSD are associated with lower adherence to continuous positive airway
pressure (CPAP), an effective treatment for OSA (El-Solh et al., 2018; Zhang et al., 2017).
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Chapter 2: Background
Review of Literature
To identify relevant literature, three databases were searched. First, Ovid MEDLINE(R)
ALL was searched for “Stress Disorders, Post-traumatic” AND (“Sleep Initiation and
Maintenance Disorders” OR “Sleep Apnea Syndromes”). Next, APA PsycInfo was searched for
Posttraumatic Stress Disorder AND (Insomnia OR Sleep Apnea). Last, PubMed was searched for
"PTSD" AND ("Sleep Disturbance" OR "Sleep Apnea”). After duplicate records and records
published prior to 2001 were removed, 645 remained. Of these, 278 were deemed relevant based
on their title, and the abstracts were screened for eligibility. Records were excluded if they were
not published in English, did not examine a treatment intervention, if the study’s intervention did
not target the sleep disturbance associated with PTSD, or if the sample included subjects with
traumatic brain injury. Sixty-eight articles were eligible and analyzed in full for inclusion.
Review articles and editorials were excluded, along with those assessing an intervention not
available in the United States. Additionally, articles were not included if they did not report a
sleep related outcome (see Appendix A). The 37 articles meeting criteria are listed in the
evidence matrix (see Appendix B), which outlines each study’s purpose, design, sample size and
composition, treatment or intervention, sleep related outcomes, PTSD related outcomes, and
level of evidence using the JBI criteria (Joanne Briggs Institute, 2013).
These articles are reviewed below. First, studies examining Cognitive Behavioral
Therapy for Insomnia (CBT-I) in subjects with PTSD are reviewed. Next, studies examining
CBT-I combined with nightmare focused psychotherapy in subjects with PTSD, followed by
studies examining CBT-I combined with trauma-focused psychotherapy in subjects with PTSD
are reviewed. Then, studies of CBT-I sequenced with trauma-focused psychotherapy in subjects
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with PTSD are reviewed. Next, studies of pharmacological treatment approaches, followed by
alternative treatment approaches for the sleep disturbance associated with PTSD are reviewed.
Treatments targeting OSA in PTSD are also reviewed. Finally, a proposed screening and
treatment protocol for patients with PTSD and sleep disturbance is outlined and conclusions and
recommendations based on the review of literature are presented.
CBT-I for PTSD
CBT-I is the recommended treatment for insomnia in the setting of PTSD according to
the VA/DoD Clinical Practice Guidelines for both for PTSD and Chronic Insomnia Disorder and
Obstructive Sleep Apnea. This recommendation finds the highest level of support from Talbot et
al.’s (2014) randomized trial comparing individual CBT-I to waitlist control in adults with PTSD
and insomnia. Participants in the study’s CBT-I arm showed significant improvement in selfreport sleep diary and sleep quality measures (P < 0.001), as well as objective measures from
polysomnography compared with participants in the waitlist arm (Talbot et al., 2014). These
improvements remained six months post-treatment (Talbot et al., 2014). In the CBT-I group,
41% of participants achieved “remission” from insomnia, compared with 0% in the control group
(Talbot et al., 2014).
Four smaller studies support CBT-I as safe and effective for patients with PTSD across a
variety of treatment settings and modalities. Gellis & Gehrman (2011) found significant
subjective improvements in sleep in a pilot study of eight Veterans with long-standing PTSD
receiving individual CBT-I, with effect sizes in the moderate to large range (0.6-3.2), but no
changes in objective measures. Two studies examined group CBT-I in a PTSD population.
DeViva et al. (2018) found significant improvements in several sleep diary measures (p < 0.05)
and Insomnia Severity Index (ISI) scores (p < 0.001) in a retrospective chart review of Veterans
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in a residential treatment program for PTSD receiving group CBT-I, and Owen (2002) found a
significant time effect of group CBT-I on sleep quality scores of Veterans with PTSD in an
inpatient setting. Efficacy of CBT-I for patients with PTSD has also been demonstrated in a telehealth modality (Franklin et al., 2018).
Despite these promising results, CBT-I is not always feasible, accepted by patients, or
successful (Akinnusi & El-Solh, 2019). To investigate factors that may predict CBT-I response
in a PTSD population, El-Solh et al. (2019) conducted a retrospective chart review of 136
Veterans with PTSD and insomnia. Of the participants who received CBT-I, 77% completed
treatment, and 47% were responsive six-months after completion, which is consistent with
Talbot et al.’s (2014) remission rate (El-Solh et al., 2019). The CBT-I non-responder group had
significantly higher pre-treatment rates of benzodiazepine and non-benzodiazepine GABA
receptor agonist prescriptions than the CBT-I responder group (p = 0.005) (El-Solh et al., 2019).
Further, younger-age and non-white race (p = 0.001) were each found to be associated with lack
of response to CBT-I (El-Solh et al., 2019).
CBT-I Combined with Nightmare Focused Psychotherapy
Given the limitations of EBPs for PTSD and CBT-I in treating the sleep disturbance
associated with PTSD, combined, novel, and sequenced psychotherapeutic strategies have been
investigated. There are four studies examining combined CBT-I with a therapy targeting PTSD
related nightmares (Imagery Rehearsal Therapy (IRT) or Exposure, Rescripting, and Relaxation
Therapy (ERRT)). Results of these studies demonstrate that combined approaches improve sleep
diary parameters and subjective sleep measures over waitlist or usual care conditions. Ulmer et
al. (2011) assessed the feasibility of a “Sleep Intervention for PTSD (SIP),” which combined
CBT-I and IRT, and found medium to large effect sizes for sleep diary parameters from baseline
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to post-intervention and very large treatment effects for insomnia severity (F3,14 = 9.88, p =
0.006) and sleep quality (F3,14 = 15.91, p = 0.001) in the SIP group (Ulmer et al., 2011).
Margolies et al. (2013) built upon these results with a larger sample, younger population, and
briefer treatment. Like the previous study, large effect sizes were found in the treatment group
for several sleep diary parameters, and there was significant improvement in measures of
insomnia severity (F (1,35) = 16.24, p < .001) and sleep quality (F (1,35) = 25.28, p < .001)
(Margolies et al., 2013). Mack (2013) combined CBT-I and IRT in a group therapy format and
found significant condition by time interactions across sleep diary scores and self-report sleep
measures with large effect size, (F (5, 26) = 3.89, p = .009, ηp 2 = .428). Similarly, a group
treatment combining CBT-I with a modified version of ERRT found medium to large effect sizes
for sleep diary measures, insomnia severity and sleep quality (Swanson et al., 2011).
Studies in this category have been included in two meta-analyses. One demonstrated that
the CBT-I component of the combined therapy had a significant effect on the degree of
improvement in sleep quality from initial assessment to post-treatment (QB (1) = 11.20, p < 0.01)
(Casement & Swanson, 2012). A second meta-analysis evaluating the efficacy of sleep-specific
CBT in treating PTSD, sleep, and depressive symptoms found large effect sizes for insomnia
severity scores (g = 1.15) and sleep quality scores (g = 0.87) in the CBT group (Ho et al., 2016).
Limitations of these combined treatment approaches should be considered. In one study,
remission rates were lower than expected for both insomnia (11%) and sleep quality (Ulmer et
al., 2011). Three of the four studies excluded participants with OSA, limiting generalizability. In
studies that included participants taking sleep medications, the medications were not
systematically tracked, leaving questions about the role of concurrent medication and
psychotherapy.
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Sleep Treatment Combined with Trauma-Focused Psychotherapy
Studies of interventions to improve treatment outcomes for Veterans with PTSD and
sleep disturbance include combined Prolonged Exposure (PE), an evidence-based therapy for
PTSD, with CBT-I, and combined Cognitive Processing Therapy (CPT), another evidence-based
therapy for PTSD with sleep directed hypnosis. Colvonen et al. (2019) piloted the “2NITE
protocol,” which consisted of two sessions of CBT-I, then PE integrated with the rest of the
CBT-I protocol, for a total of fifteen 90-minute sessions. The authors found significant
improvement in subjective and objective measures of sleep, and a significant decrease in
insomnia severity scores (d = 2.38) from pre- to post-treatment (Colvonen et al., 2019). The lack
of control condition and follow-up data limit the findings of this study; a strength was the
modification of the treatment manual to screen and treat OSA prior to the start of treatment
(Colvonen et al., 2019). A unique study compared the effects CPT with sleep-directed hypnosis
to the effects of CPT with symptom monitoring and found modest results, with participants in the
hypnosis condition demonstrating improved sleep onset compared with the symptom monitoring
condition (p = 0.4) (Arditte Hall et al., 2020).
Sequenced CBT-I with Trauma Focused Psychotherapy
There are three studies examining outcomes of sequencing CBT-I both before (Baddeley
& Gros, 2013) and after (DeViva et al., 2015, Walters et al., 2020) trauma focused
psychotherapy for PTSD. These studies show promising results, however, can’t be directly
compared due to the wide variety of treatment intervention and design. Baddeley & Gros (2013)
documented a case study of a 70-year-old Veteran with PTSD and insomnia who initially refused
PTSD psychotherapy. The treatment approach was shifted to utilize CBT-I infused with
psychoeducation about PTSD (Baddeley & Gros, 2013). DeViva et al. (2005) conducted a pilot
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study with five patients who successfully completed CBT for PTSD but continued to report
significant sleep difficulties. Treatment included CBT-I tailored to PTSD patients (DeViva et al.,
2005). In both studies, participants demonstrated improved sleep outcomes including self-report
sleep diary measures, insomnia severity and sleep quality scores (Baddeley & Gros, 2013;
DeViva et al., 2005). While these studies are limited by their very small samples (one and five,
respectively), Walters et al. (2020) studied the impact of sequencing CBT-I and IRT after PE
treatment in a larger sample of 41 subjects. This randomized controlled trial of participants with
PTSD, insomnia, and nightmares utilized a treatment consisting of twelve sessions of PE over six
weeks, followed by five weekly sessions of IRT, and seven weekly sessions of CBT-I (Walters et
al., 2020). Veterans in the control arm received PE followed by supportive care (Walters et al.,
2020). PE alone did not improve sleep efficiency or nightmares, further supporting that PTSD
psychotherapy is often not adequate to treat associated sleep-disturbance or insomnia. In the
treatment arm, there was increased sleep efficiency with large effect size compared with the
control condition (p = 0.68, d = 1.07). While comprehensive, this treatment design raises
feasibility concerns due to the length (18-weeks) and dropout rates (43% from PE; 30% from
IRT) (Walters et al., 2020).
Pharmacologic Approaches
Medications are frequently prescribed to target sleep disturbance in PTSD, however,
there is not enough evidence to recommend a specific pharmacologic approach. The two studies
of the non-benzodiazepine sedative-hypnotic eszopiclone demonstrated contradictory results.
Pollak et al.’s (2011) placebo controlled randomized trial of eszopiclone in patients with PTSD
and insomnia resulted in significant improvements in sleep onset latency (P = .044) and sleep
quality scores (P = .011). This is contrasted with Dowd et al.’s (2020) placebo controlled
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randomized trial of eszopiclone in patients with PTSD and “sleep disturbance,” that found no
significant differences between groups in sleep outcomes (Dowd et al., 2020). There are no
studies of the non-benzodiazepine sedative-hypnotic zolpidem as standalone treatment for PTSD
related sleep disturbance, however, a randomized “zolpidem-controlled” trial of patients with
PTSD taking an antidepressant that examined the benefits of hypnotherapy added to zolpidem
demonstrated similar outcomes in both groups (Abramowitz, 2008).
The atypical antipsychotics risperidone and quetiapine have been studied for their impact
on sleep outcomes in Veterans with PTSD (David et al., 2006; Krystal et al., 2016; Robert,
2005). Adjunctive risperidone was found to have a small effect on a self-report sleep quality
measure, which in one of the two studies (Krystal et al., 2016) was statistically significant (main
effect F = 4.57, P = 0.34; drug-by-time F= 4.32, P =0.14). The sole study assessing the impact of
quetiapine on sleep disturbance in PTSD was a prospective open label trial that found
significantly improved sleep duration (1.8 hours per night) and improved sleep quality scores (p
< 0.001) with quetiapine prescribed at bedtime (Robert, 2005). Given the relatively small impact
on sleep, and the significant potential adverse effects, use of atypical antipsychotics for this
purpose remains discouraged (Akinnuisi & El-Sohl, 2019).
The alpha-blocker prazosin has received attention for its potential use in PTSD treatment.
It has been “recommended” by the American Academy of Sleep Medicine guidelines for PTSD
associated nightmares (Brownlow et al., 2015). A reduction in nightmares is hypothesized to
indirectly improve sleep in PTSD. Several studies of prazosin have reported sleep outcomes.
Two meta-analyses found significantly improved sleep with prazosin over placebo (George et al.,
2016; Khachatryan et al., 2016). However, the meta-analysis by Khachatryan et al. (2016)
reports sleep outcomes using only one PTSD criteria related to sleep, with no other subjective or
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objective measures reported. Three randomized controlled trials had mixed results, with one
finding no significant effect of prazosin on actigraphy data (Khaziaie et al., 2016), one finding
increased total sleep time and REM sleep time over placebo (p < 0.01; Taylor et al., 2008), and
the last finding significantly improved sleep quality measure scores (p = 0.008, Cohen’s d = 1;
Raskind et al., 2007).
There are no controlled trials of trazodone for sleep in a PTSD sample. Warner et al.
(2001) surveyed 74 Veterans about their use of trazodone and found that 60 were able to
maintain effective doses with most (92%) reporting improved sleep onset, and three-quarters
reporting improved sleep maintenance.
Alternative Treatment Approaches
Treatment modalities often described as “alternative” have been investigated as potential
strategies to improve outcomes in patients with PTSD and sleep disturbance. These include
auricular acupuncture (AA), a Mantram Repetition Program (MRP), and exercise (King et al.,
2015; beck et al., 2017; Bosch et al., 2017). Of these, the MRP exhibited the most compelling
evidence for consideration. The 20 Veterans with PTSD and sleep disturbance participating in an
8-week manualized MRP showed a statistically significant decrease in insomnia severity scores
from pre- to post-treatment with moderate effect size (P < 0.00, d = 0.61) (Beck et al., 2017).
However, 60% of the participants continued to meet diagnostic criteria for insomnia following
the treatment (Beck et al., 2017). AA did not have promising results, as no significant differences
were found in actigraphy results or sleep quality scores from pre- to post-treatment in a Veteran
cohort (King et al., 2015). A longitudinal study by Bosh et al. (2017) suggests exercise may
improve sleep quality at one-year follow up, controlling for other variables. These studies were
limited by study design and small sample sizes.
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Approaches Targeting OSA in PTSD
Evidence suggests that treating co-occurring OSA in individuals with PTSD improves
overall treatment outcomes, including sleep outcomes. This is supported by Orr et al.’s (2017)
prospective study of Veterans with PTSD and newly diagnosed OSA naïve to CPAP therapy.
CPAP use resulted in significant improvement in patient-reported sleep quality and sleepiness
measures (p = 0.001) at three- and six-month follow-up (Orr et al., 2017). Despite the benefits of
CPAP, patients with PTSD have difficulty with CPAP adherence. For this reason, other
treatment options for OSA, such as advanced PAP therapy (APAP) and a mandibular
advancement device (MAD) have been considered. In a retrospective chart review of patients
with OSA and PTSD who “failed” CPAP and were treated with APAP, Krakow et al. (2019)
found that hours of weekly APAP use and insomnia severity were inversely correlated (r =
0.321, p = 0.001) (Krakow et al., 2019). There was significant improvement in insomnia severity
scores associated with APAP compliance (P = < 0.001; Krakow et al., 2019). When comparing
CPAP to MAD in Veterans with PTSD, El-Sohl et al. (2017) found that both treatment options
improved sleep quality significantly. While CPAP demonstrated better results for nocturnal
oxygenation and number of apneas and hypopneas than the MAD, adherence to the MAD was
significantly higher than to CPAP (P < 0.001). In a prospective cohort study, Veterans with
PTSD and OSA with and without insomnia were compared. Findings demonstrated that, in
patients with PTSD and OSA, the presence of insomnia worsened sleep and PTSD outcomes as
well as CPAP adherence (El-Sohl et al., 2018).
Screening and Treatment Protocol
A review by Colvonen et al. (2018) proposes, but does not implement, a “flow chart for
assessment and treatment of sleep disorders in PTSD” based on existing evidence (p. 2). In
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individuals with a history of PTSD and sleep problems, the authors recommend beginning with
screening and treatment for OSA, with CPAP desensitization to increase compliance if needed
(Colvonen et al., 2018). If OSA screening is negative, or once OSA is adequately treated, the
flow chart recommends screening for insomnia (Colvonen et al., 2018). If an insomnia diagnosis
is made, CBT-I is the next treatment step, followed by an evidence-based psychotherapy (EBP)
for PTSD (Colvonen et al., 2018). If insomnia is not diagnosed, direct referral to the PTSD
treatment is suggested (Colvonen et al., 2018). In both scenarios, if nightmares persist following
the EBP, a targeted nightmare therapy is recommended (Colvonen et al., 2018). A benefit of this
approach includes utilization of established treatments supported by existing evidence in which
clinicians are often already trained. It also includes prompt screening and diagnosis of both OSA
and insomnia, which acknowledges the high rates of both co-morbidities in the PTSD population
and recommends addressing them early in treatment to maximize PTSD psychotherapy benefits.
Additionally, it limits the length of overall treatment to that which the individual’s symptoms are
best matched, a strategy which could reduce treatment drop-out rates.
Conclusions and Recommendations
CBT-I is a safe and moderately effective treatment for insomnia in patients with PTSD
across different modalities and settings. However, remission rates average less than 50%.
Accessibility to this treatment is an additional concern. Treatment outcomes may be more robust
when patients engage in CBT-I before medications such as benzodiazepine and nonbenzodiazepine receptor agonists are trialed. Nightmare focused psychotherapy combined with
CBT-I has been shown to improve sleep, however, there are no studies comparing these
combined treatments to CBT-I alone. Therefore, it remains unclear if the combined treatment is
needed for all patients. Similarly, studies combining trauma-focused psychotherapy for PTSD
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with sleep interventions show improvement across symptoms compared to waitlist conditions,
but there are no comparisons to CBT-I alone. Sequencing CBT-I before or after PTSD
psychotherapy is another treatment option. Existing studies are limited by small sample sizes and
cannot be directly compared given the variety of treatment interventions employed. There is not
yet enough data to determine how to best sequence treatments, however, treating sleep
disturbance first may improve response to PTSD psychotherapy and may be preferred by patients
(Gutner et al., 2018).
The evidence for medications targeting sleep disturbance in patients with PTSD supports
prazosin for the treatment of PTSD related nightmares. While improving nightmares may
improve overall sleep, available evidence supporting prazosin’s direct effect on sleep outcomes
is mixed. Given the limited evidence and risk of adverse effects of atypical antipsychotics, and
the lack of evidence for long-term prescriptions of non-benzodiazepine sedative hypnotics, use
of these medications for this purpose is not recommended. Trazodone needs further investigation
with a higher level of evidence. Existing data of alternative treatment approaches for Veterans
with PTSD and sleep disturbance is not strong enough to support recommendation.
The studies of psychotherapeutic and pharmacological approaches often excluded
participants with OSA or did not address if they were screened for this condition. Given the high
rates of co-morbidity, and the known impact of OSA on sleep disturbance, this limits
generalizability. For those patients with PTSD and co-occurring OSA, evidence suggests that
adequate treatment of OSA can improve sleep quality and decrease insomnia severity. Options
other than CPAP, such as APAP or MAD, may improve treatment adherence in a PTSD
population. Insomnia can worsen sleep in this population regardless of adherence to CPAP
therapy. The flow chart proposed by Colvonen et al. (2018) suggests screening and treatment of
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OSA as an initial step, and screening and treatment of insomnia via CBT-I prior to PTSD
treatment. This offers a potential solution for sequencing existing evidence-based treatments for
a complex population.
Project Model
The Knowledge-to-Action (KTA) Framework, developed in 2006 by Graham et al.,
outlines the process of translating and implementing research into practice (Nilsen, 2015). The
KTA framework consists of two components: knowledge creation, visually represented as a
funnel at the center of a circle, and the action cycle, depicted as a circle surrounding the center
funnel (see Appendix C). Each component has several phases. The knowledge creation
component comprises knowledge inquiry, knowledge synthesis, and knowledge tools/products.
Knowledge inquiry represents a wide array of research, which is reduced to a smaller number of
tools or products to facilitate implementation (Sudsawad, 2007). This DNP project reviewed the
literature for treatment approaches to improve outcomes for Veterans with PTSD and sleep
disturbance. The evidence was appraised, synthesized, and narrowed to several approaches to
consider for implementation.
The knowledge creation funnel rotates and feeds into the action cycle, which contains the
components needed for knowledge implementation (Crockett, 2017). The knowledge creation
funnel can feed into the action cycle at any stage; a suggested starting point is the “Identify
Problem/Identify, Review, Select Knowledge” step (Nilsen, 2015). In this step, knowledge is
compared to current practice and chosen to appropriately close existing gaps. The protocol
selected for adaptation in this DNP project was chosen because the evidence supports it, and
because it closes the identified gaps identified in the practice setting where it will be
implemented.
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Next in the KTA Framework, knowledge is modified to adapt to the local context,
facilitators and barriers to use are identified, and interventions are selected, tailored, and
implemented (Graham et al., 2006). The adapted protocol includes the screening measures,
treatment approaches, and clinical language used where it was implemented. The action cycle of
the KTA Framework and DNP project will continue with monitoring knowledge use, evaluating
outcomes, and sustaining knowledge use (Graham et al., 2006).
Organizational Description and Assessment
This DNP project was implemented in an outpatient VA Clinic in southern New England.
This clinic is multidisciplinary, comprised of psychiatrists, psychiatric nurse practitioners,
clinical social workers, clinical psychologists, and trainees in each discipline, who manage
caseloads of various sizes. The clinic’s focus is the treatment of PTSD, anxiety disorders and
their co-morbidities in eligible Veterans. Psychiatric evaluation and diagnostic assessments are
conducted within the clinic, and Veterans are offered a variety of treatment modalities including
psychopharmacology and evidenced-based individual and group psychotherapy. Group therapy
options include two CBT-I groups, with new cohorts beginning approximately every six weeks.
Veterans with PTSD who are new to treatment, or who wish to learn more about treatment
options, are offered a referral to the clinic’s “Trauma Recovery Education Class (TREC),” a
four-session patient education and treatment-planning group that has been associated with a
higher likelihood of Veterans selecting evidence-based psychotherapies (EBPs) for PTSD
(DeViva et al., 2017). Veterans can also be referred, via electronic consult, to other clinics such
as the sleep clinic, which conducts sleep evaluations, in-laboratory, and at-home
polysomnograms, CPAP prescription and desensitization.
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Decisions about treatments offered in the PTSD clinic are made through discussion in
weekly team meetings with final approval given by the clinic director. Available treatments must
include, but are not limited to, those required by VHA Handbook 1160.01, Uniform Mental
Health Services in VA Medical Centers and Clinics. The handbook requires that treatments
conform to VA/DoD Clinical Practice Guidelines. The handbook requires VA Medical Centers
to provide access to either CPT or PE for PTSD. There are no additional requirements listed for
insomnia, sleep disturbance or OSA. According to the VA/DoD Clinical Practice Guidelines for
The Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea, there are strong
recommendations for CPAP therapy when OSA is diagnosed, and CBT-I when insomnia
diagnosed, including when there are co-morbid conditions present. Further, the guidelines give
strong support for educational, behavioral, and supportive interventions to improve CPAP
adherence in Veterans with OSA who are at high-risk for poor adherence, such as those with
PTSD or insomnia.
The review of literature supports implementation of a screening and treatment planning
protocol for Veterans with PTSD and sleep disturbance in a VA outpatient mental health setting.
Of the 37 studies included in the review of literature, 30 had samples comprised of only
Veterans, or both Veterans and non-Veterans. The screening and treatment planning protocol
selected for adaptation was developed by authors from the VA Healthcare System and the
National Center for PTSD (Colvonen et al., 2018). The screening measures and treatments
included in the adapted protocol conform with VHA Handbook 1160.0, VA/DoD Clinical
Practice Guidelines and are available within the healthcare system where the project was
implemented.
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There is consensus among clinicians in the outpatient VA PTSD clinic that the sleep
disturbance associated with PTSD is challenging to treat. They report that medications for sleep
disturbance often are inadequate and lead to undesirable short and long-term effects. Therefore,
they seek non-pharmaceutical options to offer to Veterans. They also find it challenging to
encourage Veterans to follow-up with referrals to the sleep clinic and maintain compliance with
CPAP when indicated.
The outpatient VA PTSD clinic has several strengths. First, the clinic follows VHA
Handbook 1160.01 and the VA/DoD Clinical Practice Guidelines which require and recommend
EBPs. Therefore, these therapies are consistently discussed in staff meetings, and clinicians are
trained in these modalities through training and consultation programs. Similarly, clinicians are
familiar with using standardized assessments and screening tools, which are embedded within
the electronic medical record (EMR). Finally, clinicians and Veterans have access to services
outside of the PTSD specialty, such as sleep clinic consultation and sleep studies.
Several weaknesses also exist. The high volume of screening tools and EBPs available
may lead clinicians to give less focused attention to each one or be unable to complete all
measures in the allotted time for evaluation (60-minutes) or follow-up visit (30-minutes). The
use of the EMR helps document and track care. However, relying on electronic consults for
treatment referrals can create an administrative bottleneck, which can delay treatment due to the
low number of administrative staff compared to clinical staff.
Evaluation of these strengths and weaknesses uncovers opportunities for this DNP project
to improve clinical outcomes. Clinicians are familiar with screening measures and EBPs, but do
not consistently use all of them. Presenting them in a screening and treatment protocol could
increase EBP referral and completion, fulfilling the requirements of the VHA Handbook 1160.01
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and the VA/DoD Clinical Practice Guidelines, and improving performance on local and national
EBP benchmarks. A program relevant to this project is the VA Psychotropic Drug Safety
Initiative (National Center for PTSD), which discourages the use of benzodiazepines and other
controlled substances that are often prescribed for sleep disturbances related to PTSD. A
screening and treatment protocol that does not involve medication provides clinicians an
approach to help their patients that is in line with the drug safety initiative.
External threats to this DNP project must be considered. The ongoing COVID-19
pandemic put a stop to in-person treatment groups. The clinic transitioned groups to virtual
platforms; however, some Veterans are unwilling or unable to participate in this format. The
distribution of screening tools has also been impacted, with many clinicians and Veterans
preferring written vs. electronic administration, which is not as easily accomplished in the virtual
format. Successful implementation of the treatment and screening protocol includes adequate
treatment of OSA when present. Issuing and monitoring of CPAP for OSA relies on an outside
company, over which VA clinicians have minimal control. Delays in delivery or poor customer
service could hinder successful clinical outcomes.
Aims
This DNP Quality Improvement project adapted an assessment and treatment protocol for
Veterans with PTSD and sleep disturbance for an outpatient VA PTSD clinic, and implemented
the protocol in a patient education and treatment-planning group to increase referrals to
evidence-based treatments recommended by the protocol. The aims of the project were as
follows:
1. To adapt an assessment and treatment protocol for Veterans with PTSD and sleep
disturbance for an outpatient VA PTSD clinic.
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2. To implement and evaluate the protocol in a patient education and treatment-planning
group to increase referrals to the evidence-based treatments recommended by the
protocol.
3. To make recommendations for scaling and sustainability.
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Chapter 3: Methods
This DNP Quality Improvement project adapted an assessment and treatment protocol for
Veterans with PTSD and sleep disturbance for an outpatient VA PTSD clinic and implemented
the protocol in a patient education and treatment-planning group to increase referrals to
evidence-based treatments recommended by the protocol. The aims of the project were as
follows:
Aim 1: To adapt an assessment and treatment protocol for Veterans with PTSD and sleep
disturbance for an outpatient VA PTSD clinic.
•

Development of protocol:
o An assessment and treatment protocol for Veterans with PTSD and sleep
disturbance was adapted from the “flow chart for assessment and treatment of
sleep disorders in PTSD” published in 2018 by Colvonen et al. (pg. 48, see
Appendix E). The adapted protocol was named “Evidence-Based Protocol for
Veterans with PTSD and Sleep Disturbance” (see Appendix F).
o The protocol was adapted through expert consultation with Dr. Colvonen. Dr.
Colvonen provided input on the incorporation of relevant research findings from
2018 to 2021 into the adapted protocol. He also provided input regarding the
implementation of the protocol in an outpatient PTSD clinic.
o Clinicians working in the outpatient VA PTSD clinic provided feedback about the
adapted protocol through email communication. This included feedback regarding
the protocol’s visual design, ease of use, and potential for integration into the
clinic’s procedures and standard practices.

•

Development of implementation team and plan:
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o A team was formed to implement the adapted protocol in the outpatient VA PTSD
clinic’s patient education and treatment planning group (TREC).
o The implementation team was led by this author, a psychiatric nurse practitioner
specializing in PTSD. Other team members included a clinical psychologist who
specializes in PTSD, and a psychology intern assigned to the outpatient PTSD
clinic.
o The implementation team modified the procedures and curriculum of TREC:
▪

A screening measure for OSA, the STOP Questionnaire (see Appendix G)
and a screening measure for insomnia (Insomnia Severity Index, see
Appendix H) were added to the existing PTSD screening measures
provided to Veterans attending the group.

▪

The team modified the TREC curriculum (see Appendix I) and included
patient education material (see Appendix J) about the sleep disturbance
associated with PTSD, the common co-morbidities of OSA and insomnia,
and the recommended treatments for both co-morbidities.

Aim 2: To implement and evaluate the protocol in a patient education and treatmentplanning group to increase referrals to the evidence-based treatments recommended by the
protocol.
•

Implementation in TREC:
o TREC is an established treatment group in the PTSD clinic which focuses on
patient education and treatment planning for Veterans with PTSD. It is a foursession group that runs once per calendar month. Veterans attending TREC must
have a confirmed diagnosis of PTSD and express interest in education about
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PTSD symptoms and treatments. Veterans are referred to the group by their
individual mental health treatment coordinator (MHTC).
o Each Veteran attending TREC during the implementation period was sent a STOP
questionnaire and an ISI:
▪

The STOP questionnaire is a validated screening tool for OSA (Chung et
al., 2008). A variation of the STOP questionnaire, the STOP-BANG
questionnaire, is thought to have superior predictive value compared with
other OSA screening tools, including the STOP questionnaire (Chiu et al.,
2017). The STOP is available in the VA EMR, while the STOP-BANG is
not. Therefore, the STOP was chosen for implementation.

▪

The ISI is a validated and recommended screening measure for insomnia
(Bastien et al., 2001).

o The revised TREC curriculum was delivered by members of the implementation
team.
o The implementation team held weekly meetings throughout the implementation
period. The “Patient Tracking and Protocol Fidelity Form” (see Appendix K) was
used to ensure that fidelity to the new TREC procedure and curriculum
components were followed.
o Veteran attendance, pertinent information gathered from chart review, screening
measure results, and relevant electronic referrals were also tracked using this
form.
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o Results from the returned STOP questionnaires with accompanying treatment
recommendations were communicated to the Veteran’s MHTC via formal
documentation in the EMR by the implementation team:
▪

If the Veteran had a “positive” STOP Questionnaire (answered “yes” to
two or more questions), the recommendation was that a consult to the
sleep clinic be entered.

o Results from the returned ISI’s with accompanying treatment recommendations
were communicated to the Veteran’s MHTC via formal documentation in the
EMR by the implementation team:
▪

If the Veteran scored “positive” on the ISI (score of “8” or above), the
recommendation was that a sleep assessment be completed by the MHTC
or the sleep clinic and a referral to CBT-I be made, if appropriate.

•

Evaluation:
o Descriptive statistics were used to report the following:
▪

Number of Veterans who attended each TREC session during the
implementation period.

▪

Number of TREC participants who had an existing diagnosis of OSA (per
chart review).

▪

Number of TREC participants with an existing diagnosis of OSA who
were compliant with treatment (per chart review).

▪

Number of TREC participants who were sent a STOP questionnaire.

▪

Number of TREC participants who completed and returned the STOP
questionnaire.
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▪

Number of TREC participants with a “positive” STOP questionnaire.

▪

Number of TREC participants who were sent an ISI.

▪

Number of TREC participants who completed and returned the ISI.

▪

Number of TREC participants with a “positive” ISI.

▪

Number of TREC participants receiving referrals to the sleep clinic within
60-days of their attendance in TREC.

▪

Number of TREC participants receiving referrals to CBT-I within 60-days
of their attendance in TREC.

▪

Trends in referrals to the sleep clinic and CBT-I during the
implementation period were compared to trends in referrals to these
services prior to the implementation period.

Aim 3: To make recommendations for scaling and sustainability.
•

Scaling
o Outcomes will be reported to the VA outpatient PTSD clinic.
o Clinicians will be coached to utilize the adapted assessment and treatment
protocol for Veterans with PTSD and sleep disturbance with Veterans who do not
attend TREC.
o The Evidence-Based Protocol for Veterans with PTSD and Sleep Disturbance will
be shared with two PTSD clinical teams within the regional healthcare system.

•

Sustainability
o Permanently implement the added screening measures and revised curriculum in
TREC.
o Train new TREC facilitators on the updated curriculum and procedures.
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•

Dissemination
o An abstract will be submitted to the 36th Annual American Psychiatric Nurses
Association (APNA) Conference.
o Results will be submitted for publication; the following peer reviewed journals
will be considered: Psychological Trauma: Theory, Research, Practice, and
Policy, Traumatology, and the Journal of the American Psychiatric Nurses
Association.

Human Subjects Considerations
This project was designated as a Quality Improvement project by the Yale University
Institutional Review Board (IRB). The VA Connecticut Healthcare System (VACHS) Research
Office determined that this project was not research and therefore did not require review by the
VACHS IRB or Research and Development Committee. Publication or presentation describing
the study is permitted (see Appendix L).
Project Timeline
See Appendix M for project timeline.
Systems Considerations and Implications
Leadership and Stakeholder Engagement
This author is a psychiatric nurse [practitioner working in the outpatient VA PTSD clinic
where this DNP Project was implemented and served as the project sponsor. The project was
approved by a clinical psychologist also working in the clinic who is responsible for the
facilitation of the patient education and treatment planning group. Other stakeholders included
the clinicians working in the outpatient VA PTSD clinic as well as the Veterans seeking care in
the clinic. Leadership involved included the PTSD clinic director.
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Business and Financial Considerations
This DNP Project is cost effective. It was implemented using a modest budget of $280.80
(see Appendix N for full expense budget) and has the potential to provide short- and long-term
cost avoidance, clinician time savings and satisfaction, enhanced quality and safety of care, more
efficient clinic flow, and improved patient outcomes. Aim 1, the development of the adapted
protocol for Veterans with PTSD and sleep disturbance, was accomplished utilizing existing
resources, incurring no additional cost. Aim 2, the implementation of the adapted protocol in
TREC required limited additional costs ($30.80; see Appendix N). These start-up costs supported
the addition and distribution of screening measures for OSA and insomnia, and the addition and
distribution of patient education materials about PTSD and sleep. Scaling, sustaining, and
disseminating the project, will require a small start-up cost to prepare poster presentations for
local and national conferences.
The adapted protocol for PTSD and sleep disturbance will enhance clinician satisfaction.
It synthesizes a large body of evidence by ordering screening measures and treatments in a
stepwise manner. This will save clinician time and improve collaborative treatment planning
between clinician and Veteran. The protocol contains only non-pharmacological methods for
treating the sleep disturbance associated with PTSD. This avoids costs associated with the short
and long-term prescription of sleep medications including cost per pill, cost and time associated
with follow-up medication management visits, and potential cost of complications related to
medication adverse effects including additional clinic visits and medications prescribed to
alleviate adverse effects.
Providing patient education and treatment planning for PTSD related sleep disturbance in
a group format over four 60-minutes sessions will save clinicians time and improve clinic flow.
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Providing six to eight Veterans the information via two co-leaders (eight total clinician hours) is
more efficient than providing it individually (24-32 total clinician hours). Groups have the added
value of increased patient engagement via shared treatment planning and peer support. Of note,
TREC has been associated with a higher likelihood of Veterans selecting EBPs for PTSD
(DeViva et al., 2017).
Outcomes of this project include the identification of, and referral to, evidence-based
treatment for OSA and insomnia in Veterans with PTSD and sleep disturbance. Identifying and
treating OSA in Veterans with PTSD will improve patient safety, overall health, and quality of
life as untreated OSA is linked to automobile accidents, hypertension, cardiovascular disease,
stroke, and depression. It has the potential to decrease healthcare costs associated with these
comorbidities. It will limit the prescription of sleep medications contraindicated with OSA,
further decreasing cost and risk. Similarly, identifying and treating insomnia in veterans with
PTSD will decrease healthcare costs associated with long-term treatment of insomnia such as
office visits and medications, and will increase quality of life for Veterans and their families.
Finally, treating OSA and insomnia prior to engagement in psychotherapy for PTSD will
maximize benefits of the therapy, leading to shorter episodes of care and further improving clinic
flow.
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Chapter 4: Results
Development of Adapted Protocol
The interventions outlined in Aim 1 were completed between June 2020 and January
2021. A meeting with content expert Dr. Peter Colvonen took place on June 3, 2020. Results
from this meeting included Dr. Colvonen’s permission to adapt the “flow chart for assessment
and treatment of sleep disorders in PTSD” for this DNP project. The importance of using an
algorithm for PTSD and sleep disturbance, especially in a PTSD clinic, and of screening all
individuals with PTSD for OSA was established. The potential advantages and disadvantages of
utilizing various screening measures for OSA as part of the algorithm were discussed. The
evidence for treating OSA prior to both insomnia and PTSD was confirmed. The lack of current
evidence for sequencing CBT-I before or after an EBP for PTSD was discussed, with the
recommendation being for this to remain a collaborative decision between Veteran and provider.
This information was integrated into the adapted protocol.
Feedback regarding the adapted protocol was requested from six clinicians working in the
outpatient VA PTSD clinic where the project was implemented. Two medical doctors, two
psychologists, two licensed clinical social workers and two psychiatric nurse practitioners were
asked to provide feedback regarding protocol’s visual presentation, content and feasibility of
integration into the clinic. Formatting and consult title adjustments were made based on the
feedback.
Implementation in TREC
The interventions outlined in Aim 2 were implemented in the outpatient VA PTSD clinic
from October 1, 2021, through November 30, 2021. This period included two four-session
cohorts of TREC. Eight Veterans attended at least one session of TREC during the
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implementation period. Four Veterans attended all four TREC sessions. TREC Session 1
included the curriculum components added to educate Veterans with PTSD about the common
co-morbidities of OSA and insomnia, and the impact of these on overall sleep disturbance and
functioning. Corresponding patient education material along with the two added screening
measures (STOP Questionnaire and ISI) were mailed to each veteran following Session 1. TREC
Session 2 included a review of this information and answered any questions Veterans had about
the patent education material. TREC Session 3 included a description of the evidence-based
treatment recommendations for Veterans with PTSD and sleep disturbance outlined in the
protocol. TREC Session 4 included a review of these recommendations and collaborative
treatment planning. Table 1 summarizes TREC attendance during the implementation period.
Table 1
Number of Veterans Attending TREC in the Implementation Period
TREC Cohort
TREC Session

1

October

November

Total

Session 1

6

1

7

Session 2

5

1

6

Session 3

4

11

5

Session 4

4

11

5

All Sessions

3

1

4

Sessions combined

Protocol Fidelity and Evaluation of Results
Fidelity to the adapted protocol was tracked. All Veterans who attended at least one
TREC session during the implementation period (n=8) were screened by the implementation
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team for an existing diagnosis of OSA and compliance with OSA treatment via chart review. All
eight Veterans were sent the ISI and STOP Questionnaires via US Mail. Two Veterans (25%)
returned the questionnaires to the clinic. All questionnaire results were documented in the EMR,
and MHTCs were alerted to these results and corresponding treatment recommendation. Of the
two Veterans who returned STOP questionnaires, one (50%) screened positive (indicative of
“high risk of OSA”) and one (50%) screened negative. The Veteran who screened positive was
not referred to the sleep clinic for polysomnography in the 60-day period following participation
in TREC; the reason for this is unclear. Both Veterans (100%) who returned the ISI scored in the
range indicating clinical insomnia (moderate or severe). One of the two veterans (50%) was
referred to CBT-I in the 60-day period following participation in TREC via electronic referral.
The number of sleep clinic and CBT-I referrals from these two TREC cohorts was
compared to the number of sleep clinic and CBT-I referrals from the two TREC cohort prior to
the implementation period (August and September 2021). A total of nine Veterans attended
TREC across those two cohorts. In the 60-days following each cohort, there were no electronic
referrals to the sleep clinic and no electronic referrals to CBT-I. Table 2 summarizes protocol
fidelity during implementation, and Table 3 summarizes questionnaire results and referrals.
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Table 2
Protocol Fidelity During TREC Implementation
TREC Cohort
Number of Veterans

October

November

Total

Screened for OSA

7

1

8

With existing OSA diagnosis

31

0

31

With OSA diagnosis and treatment

2

0

2

Sent STOP Questionnaire

7

1

8

Returned STOP Questionnaire

1

1

2

With positive STOP result

0

1

1

Sent ISI

7

1

8

Returned ISI

1

1

2

With positive ISI

1

1

2

adherent

1

One Veteran received OSA diagnosis during the implementation period

Table 3
Questionnaire Results and Corresponding Referrals
Veterans with

STOP Result

Referral to

ISI Result

Referral to

Returned

(+/-)

Sleep Clinic

(score)

CBT-I (Y/N)

Questionnaires

(Y/N)

Veteran 1

-

N

18

Y

Veteran 2

+

N

25

N

Note. A score of 15 or above on the ISI is indicative of clinical insomnia
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Chapter 5: Discussion and Conclusion
Despite the small sample size and limited response rate, results of this DNP project
suggest that increased screening for OSA and insomnia in an outpatient VA PTSD clinic will
uncover rates of these conditions consistent with reported prevalence rates among individuals
with PTSD. Of the two Veterans who returned STOP Questionnaires during the implementation
period, 50% screened positive for OSA. While a sleep study will be needed to confirm an OSA
diagnosis, this rate is comparable to the aggregate prevalence rate of 63% found by Zhang et al.
(2017). Both Veterans who returned the ISI scored above the cutoff for insomnia (100%); 3165% of patients with PTSD have co-morbid insomnia when the DSM diagnostic criteria are used
(Colvonen et al., 2018).
Patient education and treatment planning about evidence-based treatments for PTSD and
sleep disturbance, including co-morbid OSA and insomnia, may lead to increased referrals for
such treatments. There were no electronic referrals to the sleep clinic placed in the 60-days
following the implementation period. Several factors may have contributed to this. One Veteran
was referred to the sleep clinic just prior to his attendance in TREC and received a diagnosis of
OSA, though had not yet started OSA treatment (after meeting with the sleep clinic, the Veteran
declined CPAP and requested a referral to the dental clinic for consideration of a MAD). This
referral was not counted as it occurred prior to the implementation period. This Veteran did not
return questionnaires to the clinic; it is possible that his concurrent engagement with the sleep
clinic impacted his decision not to complete and return the screening measures. There were two
Veterans who had existing diagnoses of OSA and based on chart review, appeared to be
complaint with their OSA treatment. It is possible that having adequately treated OSA impacted
their decision not to complete or return the screening measures.
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There was one electronic referral to CBT-I in the 60-days following the implementation
period. Low numbers of CBT-I referrals may not be unique to this project or clinic. Despite
evidence recommending CBT-I as a first-line treatment for insomnia, including for insomnia that
co-occurs with other mental health conditions such as PTSD, few Veterans receive it. Across the
VA, only 0.4% of patients receive CBT-I each year (Ulmer & Hermes, 2020). It is also possible
that, despite having poor sleep, these Veterans experienced other PTSD symptoms as more
disabling and selected treatments targeting these. Aim 3 of this project includes making
recommendations for scaling and sustainability. These are outlined on the next sections.
Sustainability Modifications
Only 25% of the screening measures that were distributed to TREC participants during
the implementation period were returned to the clinic. While this limits what can be understood
from the results, it informs next steps and modifications for sustainability. Veterans attending
TREC during the implementation period were offered the option of electronic or mailed
screening measures. All eight Veterans chose mail, suggesting that this population may have a
low preference for electronic communication within their treatment. Recent studies comparing
response rates for electronic vs. mailed questionnaires have found lower rates for the electronic
method, so this preference may not be unique to Veterans with PTSD (Blumenberg & Barros,
2018).
The next step is to implement the project over a six-month period to obtain a larger
sample size and further evaluate if referrals to evidence-based treatments recommended by the
protocol are increased by the interventions. Whether or not Veterans engage in these treatments
and have improved symptoms after completing them can also be measured utilizing a longer
implementation period. Additional modifications will be made to increase screening measure
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response rates. If TREC remains virtual, Veterans will continue to be offered electronic and mail
options for distribution and collection of screening measures. Reminder calls after each group
session will be added. If TREC returns to an in-person format, screening measures will be
handed out and collected during the first session. This “paper and pencil” method is both costand time-efficient and may produce higher response rates. An application that can send
screening measures directly to a Veteran’s phone called BHL Touch was recently introduced at
the VA. The current version of BHL Touch includes the ISI but does not include the STOP or
alternate screening measure for OSA. Once included, screening measures can be administered
through this platform.
The clinical psychologist responsible for facilitation of TREC has granted permission to
permanently adopt the added screening measures, curriculum components, and patient education
materials into the group procedures. Any new facilitator of TREC will be trained to follow this
procedure and utilize the revised curriculum. Sustainability of this project is supported by the
VA’s requirement for PTSD clinics to use measurement-based care (MBC), which includes
screening measures such as the STOP Questionnaire and the ISI. VHA Handbook 1160.01 and
the VA/DoD Clinical Practice Guidelines require and recommend utilization of EBPs, which this
project is designed to encourage. Additionally, it will help prescribing clinicians comply with the
ongoing “VA Psychotropic Drug Safety Initiative,” which discourages the use of
benzodiazepines and other controlled substances often prescribed for sleep disturbances related
to PTSD. The adapted protocol does not involve medication and provides clinicians an approach
to helping their patients that is in line with the initiative.
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Recommendations for Scaling
The results of this project will be presented to the staff of the outpatient VA PTSD Clinic
on May 2, 2022. Clinicians will be asked to utilize the adapted assessment and treatment
protocol for Veterans with PTSD and sleep disturbance with Veterans who do not attend TREC
to expand the number of Veterans who can benefit. The adapted protocol will also be shared with
two PTSD clinical teams within the healthcare system. The protocol may need minor
adjustments or adaptations based on the services available to each individual PTSD clinic. PTSD
clinical teams may have different strategies for implementing the adapted protocol with their
patients based on their clinic’s structure and flow. PTSD clinics that have psychoeducation
and/or treatment planning groups like TREC may choose to implement the protocol in these
groups and can use the curriculum and patient education materials as a guide. Clinics who don’t
have an existing group could adopt the entire TREC curriculum. Clinics may also utilize these
materials during individual sessions with patients.
Dissemination
Considering the low response rate and limited results, the dissemination plan has been
revised. An abstract for a poster presentation was submitted to the 2022 American Psychiatric
Nurses Association Conference for review. The proposed poster, “PTSD and Sleep Disturbance:
A Comprehensive Treatment Approach for Veterans,” will focus on the complexities involved in
treating Veterans with PTSD and sleep disturbance, including the high rates of co-occurring
insomnia and obstructive sleep apnea, and introduce the adapted protocol as a potential approach
to evaluation and treatment. A literature review of treatments options for Veterans with PTSD
and sleep disturbance will be submitted to the Journal of the American Psychiatric Nurses
Association for potential publication. The existing literature is fragmented, with many studies
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focusing on either pharmacologic or non-pharmacologic treatments and/or excluding patients
with OSA. Nurses can benefit from a wholistic approach to this complex clinical presentation
which includes consideration of the common comorbidities of OSA and insomnia, and using an
assessment and treatment protocol like the one adapted for this project.
Conclusion
Treating the sleep disturbance associated with PTSD is a complex problem that requires a
systematic yet flexible treatment approach. The protocol adapted for this DNP project offers a
potential solution for VA clinics treating Veterans with PTSD. It provides a structured method
for screening and referring for evidence-based treatments based on the Veteran’s co-morbidities.
It supports MBC, evidenced-based practice, and drug safety initiatives. This DNP project
implemented the protocol in a patient education and treatment planning group. Given the short
implementation period and virtual group modality, the sample size was small and response rate
was limited. However, results suggest that increased screening for insomnia and OSA will
uncover high rates of co-morbidity among Veterans with PTSD. Implementation over a longer
period to obtain a larger sample is needed to assess if this method will increase referrals to the
evidence-based treatments recommended by the protocol. VA PTSD clinics will benefit from
this protocol but may need to adjust it to match the available treatment options. Similarly, each
clinic can adopt an implementation approach that fits their clinic’s unique procedures and
resources.
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Appendix A

Identification

Prisma Flow of Studies
Records identified through
PubMed database
searching
(n = 359)

Records identified through
PsycInfo database
searching
(n = 188)

Records Identified through
Ovid MEDLINE(R) ALL
database searching
(n = 352)

Screening

Records after duplicates removed
(n = 685)

Records excluded
(n = 40)
-Prior to 2001
Records after filtering published within last 20 years
(n = 645)

Eligibility

Records after titles screened for relevance
(n = 278)

Records after abstracts screened for eligibility
(n = 68)

Records after articles analyzed for inclusion in final
review
(n = 37)

Included

Records excluded
(n = 214)
-Duplicates

Studies included in ROL
(n = 37)

Records excluded
(n = 367)
-No PTSD (n = 243)
-No sleep disturbance,
insomnia or OSA (n = 107)
-Not adult (n = 17)
Records excluded
(n = 210)
-No treatment intervention
(n = 157)
-Intervention not targeting
sleep disturbance (n = 48)
-Sample included TBI (n = 5)
Records excluded
(n = 31)
-Reviews/editorials (n = 5)
-Intervention not available in
US (n = 4)
-Results did not include sleep
outcome (n = 22)

Studies included in matrix
(n = 37)

Source: Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group. (2009). Preferred reporting items for systematic reviews and
meta-analyses: The PRISMA statement. PLOS Medicine, 6(7), e1000097. https://www.doi.org/10.1371/journal.pmed.1000097

53

PTSD AND SLEEP DISTUBANCE
Appendix B
Evidence Matrix: Studies of Treatments for Veterans with PTSD and Sleep Disturbance
Author(s),
year

Study Purpose

Study
Design

Sample

Treatment/
Intervention

Sleep Related
Outcomes

PTSD Related
Outcomes

Additional
Outcomes

Participants in
both groups
showed
improvement in
non-sleep PTSD
symptoms from
baseline to
posttreatment

CBT-I was superior for
disruptive nocturnal
behaviors

Level of
Evidence
(JBI)

Notes

CBT-I for PTSD
Talbot et al.,
2014

Investigate
whether CBT-I
improves sleep,
nightmares, nonsleep PTSD
symptoms,
depression
symptoms and
psychosocial
functioning in
patients with
PTSD and
insomnia

RCT

45 adults
(Veteran and
non-Veteran)
with PTSD
and insomnia

CBT-I

CBT-I group had
statistically significant
sleep x time
improvement in sleep
diary measures:
SOL (F(1, 2697) =
20.59, P < 0.001, d =
0.82), WASO (F(1,
2695) = 22.75, P <
0.001, d = 0.93), SE (F(1,
2710) = 35.89, P < 0.001,
d = 1.06), TST (F(1,
2711) = 5.25, P = 0.022,
d = 0.30), energy level
(F(1, 2606) = 68.15, P <
0.001, d = 0.67) and PSG
measures compared to
control group;
improvement remained
6-months post-treatment
CBT-I group had
statistically significant
reductions in mean sleep
diary-measures:
SOL (t(22) = 6.31, P <
0.001, d = 1.31) and
WASO (t(22) = 4.96, P <
0.001, d = 1.03), and
increases in SE (t(22) = 7.10, P < 0.001, d =
1.48), TST (t(22) =
-3.63, P = 0.001, d =
-0.76) and energy (t(22)
= -2.19, P = 0.039, d = 0.46) from baseline
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No significant
differences between
groups for nightmares
Psychosocial
impairment dropped
significantly from
baseline to
posttreatment and
follow-up in CBT-I
group; control group’s
scores did not decrease

1.c

Commonly
prescribed sleep
medications and
OSA excluded
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assessment to 6-month
follow-up
Statistically significant
condition × time
interaction for PSQI,
(F(2, 80) = 22.13, P <
0.001, ηρ² = 0.36)
CBT-I participants had
significant reductions in
PSQI scores from
baseline assessment to 6month follow-up (t(22) =
6.86, P < 0.001, d = 1.43)
41% in CBT-I group
achieved remission from
insomnia vs. 0% in
control group

El-Solh et al.,
2019

Identify factors
that may predict
response to CBTI in Veterans with
PTSD

Retrospecti
ve chart
review

136 Veterans
with PTSDrelated
insomnia

CBT-I

CBT-I participants had
significant reductions in
ISI scores from baseline
to 6-month follow-up
(t(22) = 7.62, P < 0.001,
d = 1.59)
77% of subjects
completed CBT-I
47% subjects were
responsive six-months
after CBT-I completion
(measured by ISI
decrease of at least 6
points)
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Not reported

Statistically significant
decrease in
antidepressant usage (p
= 0.001) in those who
improved from CBT-I;
hypnotic use did not
decrease
Younger age, non-white
race (p = 0.001), and
use of benzodiazepine
and nonbenzodiazepine
receptor agonist prior to
CBT-I (p = 0.005) were
independently
associated with lack of
CBT-I response

3.c

PTSD AND SLEEP DISTUBANCE
DeViva et al.,
2018

Examined effects
of group CBT-I
in Veterans
diagnosed with
PTSD in
residential PTSD
treatment

Retrospecti
ve chart
review

47 Veterans
with PTSD in
residential
treatment

Group CBT-I

Significant
improvements in WASO,
F(1, 46) = 4.17, p < .05,
TIB, F(1, 46) = 4.06, p <
.05, SE, F(1, 46) = 4.71,
p < .05, and ISI score,
F(1, 46) = 38.8, p < .001
No significant effects for
SOL or TST

Franklin et
al., 2018

Explore
feasibility and
effectiveness of
CBT-I in rural
Veterans with
PTSD

Pilot study

18 Veterans
with
insomnia and
PTSD or subthreshold
PTSD

In-person
CBT-I vs.
telephone
CBT-I

PSQI scores in both
groups significantly
changed over time

For veterans with
available PCL-M
scores, there
were no
significant
interactions
between PTSD
score change and
any of the sleep
variables
analyzed
Not reported

Between groups: large
effect sizes favoring
CBT-I in-person at posttreatment (d = 0.77) and
1-month f/u (d = 0.10);
difference diminished at
3 months f/u (d = 0.10)

Gellis &
Gehrman,
2011

Examine effects
of CBT-I in
Veterans with
long-standing
PTSD

Pilot study

8 male
Veterans
with PTSD

CBT-I

Owen, 2002

Investigate
effectiveness of
group CBT-I in

Quasiexperiment
al design

22 inpatient
Veterans
with PTSD

Group CBT-I

Within groups: large
effect sizes for CBT-I inperson at each time point
(d = 1.00-1.61); medium
to large for CBT-I via
telephone (d = 0.55-1.33)
Statistically significant
improvements in sleep
diary: WASO (t = 2.9, p
= 0.02), TST (t = 3.3, p =
0.03), SE (t = 3.4, p =
0.01) and ISI (t = 4.4, p =
0.01)
Effect sizes in the
moderate to large range
(0.6–3.2)
No pre-to-post
differences in actigraphic
sleep
Significant time effect in
treatment group on PSQI
Wilks’ A = .308, F (2,19)
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3.c

No follow-up

No differences found in
“usefulness” or
satisfaction” between in
person and telephone
CBT-I delivery

No pre-to-post
differences on
PTSD severity

Not reported

Sleep
medications
tracked

Improved sleep quality
was not found to be
associated with lower

2.d

OSA excluded;
participants
were
not in other
active
psychotherapy
but could be on
a stable med
regimen

2.d

OSA excluded
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inpatient
Veterans being
treated for PTSD

Casement &
Swanson,
2012

Evaluate efficacy
of IR on
nightmares, sleep
disturbance, and
symptoms PTSD

= 21.37, p = .000,
multivariate r|2= .692,
indicating a large effect
size

Metaanalysis

13 studies

anxiety or depression
scores

Treatment group PSQI
scores between pretreatment and follow-up
approached significance
CBT-I Combined with Nightmare Focused Psychotherapy
Studies
At post-treatment:
At postincluding IR
Mean treatment group
treatment: Mean
and reporting
effect size large for sleep treatment group
on sleep
quality (ESWG=0.68)
effect size large
outcomes
Mean between group
for PTSD
effect size moderate for
(ESWG=0.72)
sleep quality
Mean between
(ESBG=0.64)
group effect size
large for PTSD
At follow-up:
(ESBG =0.67)
Mean treatment group
effect size moderate for
At follow-up:
sleep quality
Mean treatment
(ESWG=0.62)
group effect size
large for PTSD
(ESWG=0.93)

At post-treatment:
Mean treatment group
effect size large for
nightmares
(ESWG=0.69)
Mean between group
effect size moderate for
nightmare frequency
(ESBG=0.59)

1.b

At follow-up:
Mean treatment group
effect size large for
nightmare frequency
(ESWG =0.72)
CBT-I significantly
improved sleep quality
from initial assessment
to post-treatment,
QB(1)=11.20, p < 0.01

Ho et al.,
2016

Evaluated
effectiveness of
sleep related CBT
on PTSD, sleep
and depression

Metaanalysis

11 RCTs

Studies
comparing
sleep-specific
CBT to waitlist
controls

Effect size for ISI in
CBT group was (g =
1.15) and PSQI (g =
0.87)
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CBT for sleep
was superior to
WL/psychoeduca
tion in reducing
PTSD symptoms
(g = 0.60) and

Samples who
underwent CBTI+IR
demonstrated more
improvement in sleep
quality at post-test than
samples who underwent
IR alone
Average study attrition
rate 12.8%

1.a
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Effect sizes for SOL (g =
0.83), WASO (g = 1.02),
SE (g = 1.15)

Mack, 2013

Ulmer et al.,
2011

Investigate
effectiveness of a
group CBT-I/IRT
protocol for
nightmares and
insomnia for
Veterans with
PTSD
Assess feasibility
SIP compared to
usual care

Randomize
d trial

34 combat
Veterans
with PTSD
and chronic
insomnia

Combined
CBT-I and IRT

Randomize
d parallel
group
experiment
al design

22 Veterans
with PTSD
and insomnia

SIP (combined
CBT-I/IRT)

CAPS scores (g
= 0.6)

No significant difference
in TST
Significant condition by
time interaction across
WASO, SOL, SE, ST,
ISI, PSQI with large
effect size, F(5, 26) =
3.89, p = .009, ηp 2 =
.428
SIP group had
significantly larger
improvements in sleep
diary measures of TST
from baseline to postintervention (F1,21 6.33, p
= 0.02), WASO
(F1,21 5.91, p = 0.02),
SOL (F1,21 10.17, p =
0.004), SE (F1,21 14.61, p
= 0.001); medium to
large effect sizes

Medium to large
effect sizes for
Posttraumatic
Diagnostic Scale
(not significant)
in SIP group
Significant time
x group
interaction for
the PCL-M
(F3,14 = 17.63, p
= 0.001)

Remission rates were
lower than expected for
insomnia

1.d

Sleep disorders
excluded;
medications
included and
monitored

1.d

OSA excluded
Medications not
robustly
addressed

SIP group had
significantly greater
baseline to postintervention
improvement in
frequency of
nightmares (F1,21 5.03,
p = 5.03, p = 0.04)

Significant time x group
interaction for ISI scores
(F3,14 = 9.88, p = 0.006
and the PSQI (F3,14 =
15.91, p = 0.001); SIP
group better than usual
care at post-intervention

Margolies et
al., 2013

Examine efficacy
of combined
CBT‐I and IRT
with OEF/OIF
combat Veterans

RCT

40 OEF/OIF
combat
Veterans

Combined
CBT-I/IRT
compared to
waitlist control

No participants in usual
care remitted from
insomnia had improved
sleep quality
Significant condition x
time interaction across
sleep variables with large
effect size, F(4,29) = 5.4,
p = .002, ηp 2 = .43
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Significant
decrease in
PTSD symptoms
in CBT-I/IRT
group

Those who underwent
CBT-I had a significant
decrease in overall
distress and depression
at posttreatment

1.c

OSA excluded
Medications not
systematically
tracked
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Significant condition ×
time interactions with
large effect sizes were
seen for SE, F(1, 32) =
23.10, p < .001, SOL,
F(1, 32) = 15.23, p <
.001, and WASO, F(1,
32) = 7.43, p = .01

condition x time
F(1, 25) = 16.71,
p < .001

Participants who
underwent CBT-I had
significant decreases in
ISI scores; those in the
waitlist condition had no
significant changes
condition x time F(1,35)
= 16.24, p < .001

Swanson et
al., 2009

Investigate
outcomes of a
treatment for
nightmares and
insomnia in
veterans with
PTSD

Open
clinical
trial

Colvonen et
al., 2019

Describe a
protocol
integrating CBT-I
and PE and
present pilot data

Pilot study

10 combat
Veterans
with PTSD,
clinically
significant
ISI scores,
and recurrent
nightmares
12 veterans
with PTSD &
insomnia

10 session
group
treatment
combining
CBT-I with
ERRT

2NITE
protocol: 2
sessions CBTI, then PE and
CBT-I
integrated for
15 sessions

Participants who
underwent CBT-I had
improved PSQI scores;
participants on waitlist
had no significant
changes from baseline to
posttreatment, condition
x time F(1,35) = 25.28, p
< .001
Medium to large effect
sizes for: SE (d = 1.01),
SOL (d = 0.89), WASO
(d = 0.46), TST (d =
0.52), ISI (d = 1.70),
PSQI (d = 0.42)

Clinically significant
decrease in ISI of 11.75
points on average (d =
2.38), increase in SE by
14.97% on average (d = 3.15), increase in TST by
57.24 minutes on average
(d = 1.34), decrease in
SL (d = 1.22) and
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Large effect sizes
for Posttraumatic
Diagnostic Scale
(d = 0.42) sizes
for weekly
nightmare
frequency

Large effect for weekly
nightmare distress (d =
1.14), medium effect
for weekly nightmares
frequency (d = 0.49)

2.d

Participants
using
antidepressants
or hypnotics
were included if
meds were kept
stable

Clinically
significant
decrease in PCL5 by 20.17 point
on average (d =
1.48)

PHQ-9 decreased by an
average of 6.5 points,
which was not
significant

2.d

Authors
recommend
screening and
treating OSA
prior to the
treatment
Medications
addressed;
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decrease in WASO (d =
1.48)

Arditte Hall et
al., 2020

Examine effects
of sleep-directed
hypnosis and
CPT on sleep

Quasiexperiment
al

Actigraphy results
showed increase in SE by
10.86% on average (d = 1.56) and TST by 51.29
minutes on average (d = 1.40)
Sleep Treatment Combined with Trauma-Focused Psychotherapy
45 women
Sleep-directed
Those in the hypCPT
Not reported
with PTSD
hypnosis +
condition had
and “PTSD
CPT (hypCPT) significantly less SOL
related sleep
or symptom
than those in the
impairment”
monitoring +
ssmCPT condition at
CPT (ssmCPT) post-treatment (p = 0.4)

remained
unchanged

Controlling for sleep
medication use did not
alter intent-to-treat or
treatment completer
results

2.d

No significant effects on
WASO or TST

Significant
results likely d/t
marginally
significant preto posttreatment
increase in
SOL among
ssmCPT
participants
Sleep
medication kept
stable

Germain et
al., 2007

Examine impact
of a single
session of
combined IRT,
stimulus control,
and sleep
restriction in a
sample of adults
with PTSD

Pilot study

10
participants
with PTSD
and sleep
disturbance
(>5 on PSQI)

Baddeley &
Gros, 2013

Examine
effectiveness of
CBT-I plus
psychoeducation
about PTSD in a
patient who
refused

Case study

70 y/o male
Veteran with
PTSD and
insomnia

Single 90 min
intervention

Small→moderate
improvements in sleep
diary measures; none
statistically significant

Daytime PTSD
symptom
severity was
reduced (some
CAPS measures
Improvement in PSQI (Z statistically
= -1.87, d = 0.66, p = <
significant with p
0.1)
= <0.1; some
with p = <0.05)
Sequenced CBT-I with Trauma Focused Psychotherapy
Completed
Increased SE (70%-97%
Decreased PCL
CBT-I first,
form pre-treatment to
score from 41 to
then PE
follow-up), TST (3.5
26 from prehours to 7.5 hours from
treatment to
pre-treatment to followfollow-up
up), decreased ISI score
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2.d

CBT-I may help
motivate patients for
PTSD treatment

4.d

OSA not
addressed
Sleep apnea
excluded

Veteran had
several med
trials with
varying
compliance
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DeViva et al.,
2005

Walters et al.,
2020

Abramowitz,
2008

psychotherapy for
PTSD
Examine effects
of a tailored
CBT-I treatment
on PTSD
treatment
responders who
reported ongoing
insomnia
Examine impact
of PE on sleep
assessments;
assess impact of
sequencing
evidence-based
sleep
interventions
after PTSD
treatment on
sleep and PTSD
symptoms

Examined benefit
hypnotherapy
added to
zolpidem in
patients with
chronic PTSD

Pilot study

Parallel
groups
RCT

Randomize
d,
zolpidemcontrolled
trial

5 veterans
who
successfully
completed
CBT for
PTSD

CBT-I tailored
to PTSD
patients

41 Veterans
and activeduty service
members

PE followed
by combined
CBT-I & IRT
compared to
PE followed
by supportive
care

32 patients
with PTSD,
on SSRI and
supportive
therapy

from 26 to 7 from pretreatment to follow-up
PSQI and ISI scores
improved from pre- to
post-treatment
Sleep diary measures
improved pre- to posttreatment (Cohen’s d
from 0.12-1.7)
PE did not improve sleep
efficiency
IRT/CBT-I group had
more improvement in
insomnia (SE) with large
effect size, relative to
SCT (p = .068, d = 1.07)

At treatment end,
subjects who underwent
CBT-I did not meet
insomnia threshold;
subjects who underwent
supportive care did
Pharmacologic Approaches
Zolpidem
TST identical for both
10mg qHS x14 treatment groups; a
nights vs.
significant main effect
symptom was found for assessment
oriented
time (F(2, 60) = 23.4; p <
hypnotherapy
.0005); treatment
2x/week x 2
efficacy was similar in
weeks
both groups for quality of
sleep; quality of sleep
was higher in the
hypnotherapy group
compared to the
zolpidem group (F(1, 30)
= 10.7; p = .003) and was
improved from
the first to the second
assessment (F(2, 60)
=24.2; p < .0005); sleep
quality was significantly

61

Small
improvement in
CAPS scores
(not significant)
Daytime PTSD
symptoms
improved after
combined sleep
interventions

Significant main
effect in the
treatment group
(F(1, 30) = 4.96;
p = .034) PTSD
symptoms lower
in the
hypnotherapy
group compared
to the zolpidem
group;
significant main
effect of the
assessment
time (F(2, 60) =
43.32; p < .0005)

Qualitative results

2.d

One participant
self-tapered
sleep
medication

PE did not improve
nightmares

1.c

Participants on
hypnotics or
prazosin were
excluded

Large improvements in
nightmare frequency in
IRT/CBT-I group
relative to supportive
care that did not reach
statistical significance

2.d
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Krystal et al.,
2016

Impact of
risperidone on
sleep impairment
in Veterans with
PTSD

Multicente
r RCT

David et al.,
2006

Examine effects
of adjunctive
risperidone on
nightmares and
sleep disruption
on sleep
symptoms in
PTSD

Openlabel,
flexible
dose trial

267 Veterans
with PTSD
who were
symptomatic
despite
treatment
with other
medications
20 male
combat
Veterans
with PTSD
and partial
response to
current
medications

Adjunctive
risperidone

Risperidone 13mg at
bedtime

improved in the
hypnotherapy group
compared to
the zolpidem group (F(2,
60) = 30.9, p < .0005);
MNA’s were identical
for both treatment
groups;
MNA’s decreased more
in the hypnotherapy
group than in the
zolpidem group (F(1.6,
46.5) = 6.7, p = .006)
Risperidone group had a
small statistically
significant effect on
PSQI scores (main effect
F = 4.57, P = 0.34; drugby-time F = 4.32, P =
0.14)
PSQI decreased, but not
significant (P = 0.05)
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Reductions in
PTSD symptom
severity were
correlated with
improvements in
sleep quality

1.c

Total CAPS
score, ‘‘recurrent
distressing
dreams of the
event,’’ and
‘‘difficulty
falling or staying
asleep’’ were
improved at 6
weeks (P = 0.04,
0.04, 0.01
respectively)

2.d
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Robert, 2005

Assess impact of
quetiapine on
sleep disturbance
related to PTSD

Prospectiv
e openlabel trial

20 combat
Veterans
with PTSD

Quetiapine at
nighttime

Significantly improved
sleep (PSQI) p = <0.001
Sleep length increased
from 4.0 ± 1.0 to 6.0 ±
1.8 hours per night

Pollack et al.,
2011

Examine efficacy
and tolerability of
short-term use of
eszopiclone in
PTSD w/ comorbid insomnia

Placebo
controlled
RCT

24 patients
with PTSD
and sleep
disturbance

Eszopiclone
3mg x3 weeks,
placebo x3
weeks, 1 week
“wash-out”
between

SL (P = .044) and PSQI
(P = .011) scores
significantly improved in
eszopiclone group
compared to placebo;
there was a nonsignificant increase in
TST

Dowd et al.,
2020

Evaluate efficacy
of eszopiclone vs.
placebo for
patients with
insomnia and
PTSD

Placebo
controlled
RCT

25 patients
with PTSD
and sleep
disturbance

Eszopiclone
3mg at
bedtime x 12
weeks

No significant difference
between groups on PSQI,
self-report or actigraphy
data of SL and TST

Warner et al.,
2001

Assess
effectiveness and
tolerability of
trazodone for
sleep in a PTSD
population

Survey/que
stionnaire

74 Veterans
in an
inpatient
treatment
program for
PTSD

Trazodone 50200mg at
bedtime

Examine impact
of prazosin on
nightmares, sleep
disturbance, and
symptom severity
in adults with
PTSD

Metaanalysis

6 RCTs

Prazosin

60 patients maintained an
effective dose of
trazodone
92% reported it helped
with sleep onset,
78% reported improved
sleep maintenance
Prazosin better than
placebo in improving
sleep quality CAPS Item
13 (SMD = 0.93, 95% CI
[-0.02, 1.88], p = .054)
PSQI (SMD = 1.14, 95%
CI [0.24, 2.03], p = 0.01)

George et al.,
2016
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2.d

CAPS (P = .003)
and SPRINT (P
= .032) scores
were
significantly
improved in
eszopiclone
group compared
to placebo
No significant
difference
between groups
on CAPS or
SPRINT, even
when sleep items
removed posthoc

Prazosin was
better than
placebo at
improving
symptom
severity (SMD =
1.20, 95% CI

1.c

No significant
difference between
groups on the MADRS,
CGI or Range of
Impaired Functioning
Tool

1.c

High drop-out
rates for
eszopiclone
group (50%)

72% found trazodone
helpful in decreasing
nightmares (average 3.3
to 1.3 nights per week)

5.c

Significant
correlation
between the
decreased
nightmares and
improved sleep

9 patients reported
priapism
Prazosin was better
than placebo in
improving nightmares
(SMD = 1.022, 95% CI
[0.41, 1.62], p = .001)

1.a
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Khachatryan
et al., 2016

Examine efficacy
of prazosin for
nightmares and
other sleep
disturbances in
adults with PTSD

Metaanalysis

6 RCTs

Prazosin

Prazosin was more
effective than placebo in
improving sleep quality
(g = 0.987, 95% CI:
[0.324–1.651])

Khaziaie et
al., 2016

Assess impact of
prazosin on sleep
and nightmares
among veterans
with chronic
PTSD

RCT

32 Veterans
with combat
related PTSD
and
distressing
nightmares

Prazosin x 8
weeks

Prazosin had no
significant effect on
sleep quality measured
by actigraphy compared
to placebo

Raskind et al.,
2007

Evaluated effects
of prazosin on
nightmares, sleep
quality, or
depression

RCT

Prazosin x 8
weeks

Prazosin group improved
significantly over
placebo p =.008, Cohen’s
d=1

Taylor et al.,
2008

Evaluate effect of
prazosin on sleep
and PTSD
symptoms

Randomize
d placebocontrolled
crossover
trial

40 Veterans
with PTSD
and traumarelated
nightmares
and sleep
disturbance
13 civilians
with chronic
PTSD

King et al.,
2015

Assess feasibility
& acceptability of
AA for OEF/OIF
Veterans with

Pilot study

20 OEF/OIF
Veterans
with PTSD
and self-

Prazosin

TST was greater in the
prazosin condition than
placebo (374 +/-86 min
vs. 280=/-105 min, p
<0.01, Cohen’s d = .98)
REM sleep time was
greater in the prazosin
condition than placebo
(138=/-63 min vs. 97=/70 min, p <0.01 Cohen’s
d = .62)
SOL did not differ
between conditions
Alternative Treatment Approaches
Auricular
No significant
Acupuncture
differences in actigraphy
results or PSQI pre- to
post-treatment
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[0.79, 1.61], p =
.001)
Prazosin was
more effective
than placebo in
reducing PTSD
symptoms (g =
0.699, 95% CI:
[0.139–1.260])
and sleep
disturbances (g =
0.799, 95% CI:
[0.391–1.234])
Prazosin had no
significant effect
on reducing
daytime
symptoms of
PTSD compared
to placebo

1.a

Prazosin had no effect
on improving traumarelated nightmares
compared to placebo

1.c

No subjective
measurement of
sleep quality

1.c

PCL-C scores
decreased from
baseline more in
prazosin than
placebo group
(all p < .05)

CAPS distressing
dreams scores
decreased from baseline
more in prazosin than
placebo group (all p <
.05)

1.c

2.d

Excluded sleep
apnea; Veterans
were in a
residential
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Beck et al.,
2017

PTSD and sleep
disturbance;
examine efficacy
of AA on sleep in
this population
Assess efficacy of
MRP on
insomnia
in participants
with PTSD and
sleep disturbance

reported
sleepdisturbances

PTSD program,
undergoing
CPT
concurrently

Quasiexperiment
al

20 Veterans
with PTSD
and sleep
disturbance

Mantram
repetition
program

Exercise

Bosch et al.,
2017

Explore
relationship
between exercise
and sleep among
Veterans with
PTSD symptoms

Longitudin
al
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OEF/OIF/ON
D Veterans
with PTSD

Krakow et al.,
2019

Investigate
effects of
advanced
PAP therapy on
insomnia in
PTSD patients
with OSA

Retrospecti
ve chart
review

96 patients
with OSA
and PTSD
who failed
CPAP and
were
prescribed
APAP

There was a statistically
significant decrease in
ISI scores pre- to
posttreatment with
moderate
effect size (P < .00, d =
0.61)

PCL-S had a
statistically and
clinically
significant
decrease in with
large effect size
(P < .001, d =
0.80)
Engagement in
exercise did not
yield statistically
significant
association with
PTSD symptoms

Engagement in exercise
was significantly
associated with better
sleep quality (measured
by PSQI) at one-year
follow-up controlling for
other factors (β = -0.128,
p < 0.05).
Approaches Targeting OSA in PTSD
Advanced PAP Hours of PAP use and
Not reported
therapy such as insomnia severity were
ABPAP or
inversely correlated
ASV
(P = 0.001, r = - 0.321).
Significant main effect
(P < 0.001) for decreased
ISI scores as well as a
group by time interaction
(P = 0.039)

60% of participants still
met clinical criteria for
insomnia at posttest

2.d

3.e

Patients with PTSD
may adapt to PAP
therapy if given option
of advanced PAP

3.c

Degree of insomnia
remained significant
even with advanced
PAP

17 patients were
on no sleep
meds,
21 on one, and
58 were on two
or more

Sedating medications
reported and used were
associated with smaller
insomnia improvements
Orr et al.,
2017

Examine if
treatment of OSA
with PAP reduces
PTSD symptoms

Prospectiv
e study

59 Veterans
with PTSD
and new
diagnosis of
OSA naïve to
PAP therapy

CPAP

Self-reported sleep
duration did not change
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Significant
reduction in
PCL-S across
treatment (60.6 ±
2.7 versus 52.3 ±
3.2 points; p <
0.001)

PTSD inclusion
criteria: hx of
traumatic
exposure and
PSS score >21

3.e
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El-Solh et al.,
2018

El-Sohl et al.,
2017

Determine impact
of insomnia on
outcomes in
Veterans with
PTSD and OSA
before and after
CPAP therapy

Compare
efficacy,
adherence, and
preference for
CPAP versus
MAD, compare
effect of CPAP
and MAD on
outcomes in
veterans with
PTSD

Prospectiv
e cohort
study

Randomize
d crossover
trial

72 Veterans
with PTSD
and OSA
with and
without
insomnia

42 Veterans
with PTSD
and newly
diagnosed
OSA

CPAP

12 weeks with
CPAP and 12
weeks with
MAD with 2week wash-out

In insomnia group, ISI
decreased but not
significantly after CPAP
therapy
“Resolution of
sleepiness” for
31.5% of PAP-adherent
and 12.8% of PAP-nonadherent patients with
insomnia, compared with
52.1% of PAP-adherent
and 30.4% of PAP nonadherent patients with
PTSD and OSA only
No decrease in PSQI in
insomnia group; scores
did decrease in the PTSD
+ OSA only group
In CPAP arm:
PSQI score improved
from 11.57 ± 4.02 to 9.63
± 3.52 (P = .001).
In MAD arm:
PSQI improved from
10.96 ± 3.04 to 8.36 ±
2.58 (P < .001)

PTSD symptoms
declined for both
groups after
CPAP therapy,
but decreased
less in the
insomnia group

Veterans with insomnia
had significantly lower
CPAP compliance than
those without

3.c

Compared to
baseline, PCL-M
scores decreased
with estimated
effect sizes
(Cohen’s d) of
0.27 (95% CI
0.01 to 0.59; P =
0.04)

PAP was more
successful in reducing
AHI (P < .001) and
improving nocturnal
oxygenation (P = 0.04)
than MAD

1.d

No significant
difference in the
extent of PTSD
improvement
using either
CPAP or MAD

Compliance with MAD
was significantly higher
than CPAP (P < .001),
with 58% preferring
MAD to CPAP

AA-Auricular Acupuncture, ABPAP-Autobilevel Positive Airway Pressure, AHI-Average Hypopnea Index, ASV- Adaptive Servo-Ventilation, CAPS-Clinically Administered
PTSD Scale, CBT-I-Cognitive Behavioral Therapy for Insomnia, CGI-Clinical Global Impression, ERRT-Exposure Relaxation and Rescripting Therapy, IR-Imagery Rehearsal,
IRT-Imagery Rehearsal Therapy, ISI-Insomnia Severity Index, MADRS- Montgomery and Åsberg Depression Rating Scale, OSA-Obstructive Sleep Apnea, PAP-Positive Airway
Pressure, PCL-5-PTSD Checklist for DSM-5, PCL-C-PTSD Checklist-Civilian, PCL-M-PTSD Checklist-Military, PE-Prolonged Exposure, PHQ-9-Patient Health Questionnaire,
PSG-Polysomnogram, PSQI-Pittsburgh Sleep Quality Index, PTSD-Post-traumatic Stress Disorder, PSS-PTSD and Suicide Screener, RCT-Randomized Controlled Trial, SE-Sleep
Efficiency, SIP-Sleep Intervention for PTSD, SOL-Sleep Onset Latency, ST-Sleep Time, TIB-Time in Bed, TST-Total Sleep Time, WASO-Wake After Sleep Onset, WL-Waitlist
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Appendix C
Project Model: Knowledge to Action Framework

Knowledge to Action Process. Reprinted from “Lost in Knowledge Translation: Time for a Map,” by I.D.
Graham et al., 2006, Journal of Continuing Education in the Health Professions, 26(1), p. 19. Copyright (2015)
by Wiley Periodicals, Inc. Reproduced with permission from Wolters Kluwer Health, Inc.
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Appendix D
SWOT Analysis: Outpatient VA PTSD Clinic
Strengths
•

•
•
•
•

•

•

Weaknesses

Clinic follows VHA Handbook 1160.01,
Uniform Mental Health Services in VA
Medical Centers and Clinics which
requires EBPs for PTSD and following
VA/DoD Clinical Practice Guidelines
Clinic follows VA/DoD which
recommends EBPs listed in screening and
treatment planning protocol
Clinic promotes implementation of EBPs,
trainings/consultations offered to
clinicians
Screening measures available in EMR
Clinicians/Veterans have access to sleep
clinic services
Opportunities

•

Presenting screening measures and EBPs
in comprehensive protocol may increase
utilization, thus supporting the VHA
Handbook requirements and adherence to
VA/DoD Clinical Practice Guidelines
Project supports VA Psychotropic Drug
Safety Initiative, encouraging nonpharmacologic interventions

•

•
•
•

High number of EBPs can lead to less
focus on specific EBP (“EBP fatigue”)
Large clinic, can lead to smaller/divided
workgroups with different focuses
Low number of administrative staff
manages scheduling electronic referrals
which can lead to delay
PTSD clinic and sleep clinic operate
independently

Threats

•

68

Ongoing COVID-19 pandemic means
treatment groups now virtual
-Some decline participation virtually
-Technical difficulties arise
-Difficulty obtaining completed screening
measures remotely
Issuing Monitoring CPAP done by outside
company; limits VA oversight
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Appendix E
Flow chart for assessment and treatment of sleep disorders in PTSD

Flow chart for assessment and treatment of sleep disorders in PTSD. Reprinted from “Recent Advancements in
Treating Sleep Disorders in Co-Occurring PTSD” by P.J. Colvonen et al., 2018, Current Psychiatry Reports,
20(7), p. 48. Reproduced with permission.
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Appendix F
Adapted Protocol

Evidence-Based Protocol for Veterans with PTSD and Sleep Disturbance
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Appendix G
STOP Questionnaire
1. S noring
Do you s nore loudly (louder than talking or loud enough to be heard through closed doors)?
Yes No
2. T ired
Do you often feel t ired, fatigued, or sleepy during daytime?
Yes No
3. O bserved
Has anyone o bserved you stop breathing during your sleep?
Yes No
4. Blood p ressure
Do you have or are you being treated for high blood p ressure?
Yes No
High risk of OSA: answering yes to two or more questions
Low risk of OSA: answering yes to less than two questions

STOP Questionnaire. Reprinted from “A Tool to Screen Patients for Obstructive Sleep Apnea,” by F. Chung et al., 2008, Anesthesiology, 108, p. 821.
Copyright (2008) by Wolters Kluwer Health, Inc. Reproduced with permission from Wolters Kluwer Health, Inc. and Copyright Clearance Center.
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Appendix H
Insomnia Severity Index
For each question, please CIRCLE the number that best describes your answer.
Please rate the CURRENT (i.e. LAST 2 WEEKS) SEVERITY of your insomnia problem(s).
Insomnia problem
1. Difficulty falling asleep
2. Difficulty staying asleep
3. Problem waking up too early

None Mild Moderate Severe Very severe
0
1
2
3
4
0
1
2
3
4
0
1
2
3
4

4. How SATISFIED/DISSATISFIED are you with your CURRENT sleep pattern?
Very Satisfied
0

Satisfied
1

Moderately Satisfied
2

Dissatisfied
3

Very Dissatisfied
4

5. How NOTICEABLE to others do you think your sleep problem is in terms of impairing the quality of your life?
Not at all
Noticeable
0

A Little

Somewhat

Much

Very Much Noticeable

1

2

3

4

6. How WORRIED/DISTRESSED are you about your current sleep problem?
Not at all
Worried
0

A Little

Somewhat

Much

Very Much Worried

1

2

3

4

7. To what extent do you consider your sleep problem to INTERFERE with your daily functioning (e.g. daytime fatigue, mood,
ability to function at work/daily chores, concentration, memory, mood, etc.) CURRENTLY?
Not at all
Interfering
0

A Little

Somewhat

Much

Very Much Interfering

1

2

3

4

Guidelines for Scoring/Interpretation:
Add the scores for all seven items (questions 1 + 2 + 3 + 4 + 5 +6 + 7) = _______ your total score
Total score categories:
0-7 = No clinically significant insomnia
8-14 = Subthreshold insomnia
15-21 = Clinical insomnia (moderate severity)
22-28 = Clinical insomnia (severe)
(Copyright, Charles M. Morin, 1993).
Insomnia Severity Index. Reprinted from “Validation of the Insomnia Severity Index as an Outcome Measure for Insomnia Research,” by C.H.
Bastien et al., 2001, Sleep Medicine, 2(4), p. 299. Copyright (2001) by Elsevier. Reproduced with permission from Elsevier and Copyright Clearance
Center.
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Appendix I
Revised TREC Manual

Trauma Recovery Education Class Manual

Jason C. DeViva, Ph.D., Gwendolyn A. Bassett, MSW, Gia M. Santoro, APRN, Lisa Fenton,
Psy.D., Lashauna Cutts, MSW, & Andrea Williams, MSW

Updated July 30, 2021, by Gia Santoro, MSN, APRN, PMHNP-BC & Jason C. DeViva,
Ph.D.
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Overview
The Trauma Recovery Education Class (TREC) is a four-session education and treatmentplanning group for veterans diagnosed with posttraumatic stress disorder (PTSD) that was
developed at an outpatient VA PTSD Clinic in 2011. The primary purpose of TREC is to help
veterans make educated choices while developing their plans for PTSD treatment. The group
includes the following components:
1) Education: Veterans are educated about the definition and frequency of trauma and the
diagnostic criteria and associated features of PTSD. Specific treatment options are also
discussed in detail, including their general demands and likely effectiveness
2) Problem identification: Veterans are encouraged to identify PTSD-related problems they
are currently experiencing. Veterans then use cost/benefit analysis to determine whether
other aspects of their lives are potentially problematic and therefore targets for change.
3) Identification of barriers to care: Veterans receive information on common barriers to
care and discusses ways to circumvent them. Veterans are encouraged to identify which
barriers are most relevant to them.
4) Treatment-planning: Group members select their next step in treatment from the
available clinic options.
The TREC group is appropriate for veterans diagnosed with PTSD who are ambivalent about
treatment or who have not developed specific treatment plans and who wish to hear a
comprehensive list of treatment options. Veterans who are well-informed about PTSD and express
clear motivation for clinically indicated treatment (e.g., a veteran diagnosed with PTSD requests
prolonged exposure) may not need TREC.
Group format
TREC is a four-session group that meets weekly for 60 minutes. We recommend that the
group’s schedule be synchronized with some other aspect of the calendar (e.g., group starts the first
Tuesday of each calendar month) so that program clinicians can reliably predict group start dates
and can easily refer veterans. One or two staff can facilitate the group. We recommend it be
provided in a room with a place where material can be written for the group to see (e.g., a dry-erase
board). It is also helpful to provide group members with folders to encourage them to keep the
educational handouts provided during the course of the group.
Because of the educational nature of the group, it can be run with up to 10 members.
Homework is assigned at the end of the first, second, and third sessions. Because each session
begins with a review of the previous session, veterans can miss sessions 1, 2, or 3 and still complete
the group. We recommend that veterans missing more than one session of the group repeat the
entire group the next time it is offered. If the fourth session is missed, the veteran can either attend
the next cycle of the group or develop a treatment plan individually with another provider,
depending on the organization of the clinic.
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Trainees
Staff can co-facilitate the group with trainees. The experience of co-facilitating the group can
orient trainees to a clinic’s conceptualization of PTSD and its treatment options. Co-facilitating also
provides staff an opportunity for in vivo observation of trainees providing basic psychoeducational
information on trauma and its effects.
Assessment
Because the TREC group results in a treatment plan that can be implemented as soon as
circumstances allow, it serves as an excellent opportunity to implement assessment instruments
measuring PTSD symptoms and other relevant constructs (e.g., depression symptoms, substance
use, sleep, quality of life). The goals of the group are to maximize motivation for change and change
maladaptive beliefs about PTSD treatment, so it is unlikely that PTSD symptoms would change over
the four sessions. However, motivation and beliefs might be expected to change, so clinicians may
choose to measure these constructs before and after the group.
Subthreshold PTSD
Depending on a clinic’s purpose and situation with a larger mental health service, it may be
useful to be able to provide the TREC group to veterans with sub-threshold PTSD symptoms.
Given that there is evidence supporting the use of trauma-focused treatment with sub-threshold
PTSD and that most non-trauma-focused treatments offered to veterans with PTSD are not
necessarily PTSD-specific (e.g., anger management, stress management/relaxation), the TREC
protocol can be easily modified to work for a group of veterans with posttraumatic symptoms who
do not all necessarily have PTSD.
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Session 1 Contents
I.

Group structure and rationale

II.

Introductions

III.

Group rules

IV.

Definition of trauma

V.

Diagnostic criteria and associated features of PTSD

VI.

Why symptoms persist

VII.

Avoidance

VIII. Homework
I.

Group structure and rationale

Facilitators explain that the group will meet four consecutive weeks at the same time in the
same place. Attendance at all four groups is strongly recommended, as the content of later sessions
builds on that of previous sessions. Facilitators also emphasize that the purpose of the group is
learning about the effects of trauma, identifying problems to target, identifying and when necessary,
breaking through barriers, learning about treatment options, and selecting a treatment plan. It is
helpful to remind group members that the purpose of the group is not to decrease PTSD symptoms,
but instead for them to identify how they would like to accomplish that.
II.

Introductions

At this point, the facilitators may choose to note that this group is sometimes called a “class”
because it emphasizes the provision of information more than some other groups might. The group
is designed for veterans who are diagnosed with PTSD, so everyone in the group will have that
diagnosis. As such, veterans do not need to disclose the traumatic events they have experienced or
even their era of service if they do not want to. We recommend that group facilitators suggest that
veterans do not share details of past traumatic events as this can be distressing to other group
members. Group facilitators then introduce themselves.
Group members are asked to provide their names (how they would like to be addressed in
the group) and one thing about themselves they would like to change. Generally, veterans provide
specific and predictable targets for change (e.g., sleep, nightmares, anger, interactions with others).
Sometimes, veterans will state that they want to change “everything.” Other veterans might refer to
“my PTSD” broadly. We recommend that facilitators encourage group members who respond in
these ways to identify more specific targets (“If you had to pick one thing today, it can be different
tomorrow or next week…”). It can be helpful for facilitators to record the targets for change so that
they can be referred back to when discussing the diagnostic criteria for PTSD.
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III.

Group rules

Experienced facilitators may have their own preferred methods of explaining rules for group
attendance and participation. They may use those preferred methods. We tend to focus on two
specific rules: treating everyone in the room with respect (not interrupting others, accepting that
everyone can have different experiences and opinions, not judging, etc.) and confidentiality (not
repeating what other veterans say in group, facilitators ask group members whether they would like
to add any rules to the list.
IV.

Definition of trauma and diagnostic criteria

Facilitators provide the definition of what trauma is, according to the DSM5, and describe
the four symptom clusters of diagnostic criteria for PTSD. We recommend that facilitators make
this process interactive and involve group members in the discussion (e.g., “What makes something
traumatic?” “The first group of diagnostic criteria is re-experiencing symptoms; how do you think
people might re-experience trauma?”). It is helpful for facilitators to emphasize the broad range of
events that can be classified as trauma and to present the high proportion of the general population
that experiences at least one traumatic event (70-90%) as well as the lifetime prevalence of PTSD (810%). Facilitators will also note that depression and maladaptive substance use commonly co-occur
with PTSD.
Facilitators discuss the high number of veterans with PTSD who have sleep disturbance
(90%). Veterans should be informed that the sleep disturbance associated with PTSD can be
multifactorial and include one or both common comorbidities of insomnia obstructive sleep apnea
(OSA). The rate of insomnia among veterans with PTSD is 30-60%, and the rate of co-occurring
OSA may be as high as 63%. A basic definition of insomnia can be provided: “Insomnia disorder
involves persistent (occurring for at least three nights per week for at least three months) difficulty
with sleep initiation, duration, consolidation, or quality that occurs despite adequate opportunity and
circumstances for sleep, and results in some form of daytime impairment.” A basic definition of
obstructive sleep apnea can also be provided: “Sleep apnea is a breathing problem that disrupts
normal sleep.” People with sleep apnea may wake up not feeling rested and struggle with feeling
tired or needing to sleep during the daytime.
Facilitators may refer to group members’ targets for change and discuss how they
correspond to diagnostic criteria and associated features of PTSD.
V.

Why symptoms persist

The discussion of why symptoms persist can be difficult because veterans may blame PTSD on
negative aspects of their personality or make-up (e.g., “I still have this because I’m weak”; “this
means I can’t deal with it”). We recommend focusing on the more common cognitive-behavioral
models of the development and maintenance of PTSD.
1) The trauma and the emotions it evoked in the moment (primarily fear/anxiety) become
associated with stimuli that were present at the time, including aspects of the traumatic event
that were objectively threatening as well as other elements that were not dangerous. These
non-threatening stimuli may then elicit anxiety in the future. The stimuli are avoided because
of this anxiety, so the brain never has a chance to learn that the stimuli are not dangerous.
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This can be illustrated with any examples the facilitators want to use. For example, the
facilitator may describe an individual who is bitten by a large brown dog while walking along
a street. The individual was bitten by that specific dog, but the anxiety felt in the moment
may also become associated with the location (e.g., that street corner), what the individual
was wearing (e.g., red jacket), or the time of day (e.g., evening). These stimuli will then elicit
anxiety in the future, and if the individual avoids them, he or she will never have the
opportunity to learn that they are safe.
2) Veterans may judge how they acted or reacted during the trauma and may also blame
themselves for how the traumatic event transpired. These judgments can generate unpleasant
emotions and distress and can prevent the veteran from understanding how the trauma fits
into the context of the rest of their experiences.
As with the previous example, facilitators may illustrate this in any way they wish. They may
describe examples where veterans may have had the fight/flight/freeze response and then
judged themselves for this without appreciating the automatic nature of these emergency
responses. They may also provide examples of veterans who think that if they had acted
differently, negative outcomes would not occur (e.g., a soldier who sees a friend die and
thinks she could or should have done something to prevent it). Facilitators can discuss how
these judgments can interfere with the processing of other emotions related to the trauma.
Facilitators should emphasize that at this time research has not yet determined why some
individuals experience trauma and develop PTSD while others experience trauma and return to
baseline functioning.
VI.

Avoidance

We recommend that facilitators discuss the role of avoidance in maintaining PTSD
symptoms. It is important to have the group discuss the wide range of avoidant behaviors and how
avoidance relates to PTSD to prevent members from avoiding group and help members make a
more thorough assessment of current problems in session 2. Facilitators should attempt to solicit
examples of avoidance from the group (e.g., crowds, trauma reminders) and should provide them
themselves if the group does not. It is helpful for facilitators to note that though avoidance is part of
the diagnostic criteria of PTSD and one of the possible means by which posttraumatic symptoms
persist, individuals with PTSD often think of avoidance as a “coping mechanism” because it
decreases anxiety and brings some symptom relief in the short-term.
VII.

Homework

Homework at the end of session 1 includes reading on trauma, PTSD, avoidance, and PTSD
related sleep disturbance. The materials provided by the VA’s National Center for PTSD
(www.ptsd.va.gov) can be used, though facilitators can use any materials with which they are
comfortable. It is recommended that facilitators discuss the importance of homework with the
group when it is assigned in session 1. Facilitators should emphasize the role that homework plays in
specific treatments available in the clinic and should inform the group that each subsequent group
will begin with review of the homework.
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Session 2 Contents
I.

Homework review

II.

Problem identification

III.

Pro/con analysis

IV.

Homework
I.

Homework review

Facilitators begin the session by reviewing the homework. Facilitators can ask veterans
whether they completed the homework. For veterans who did not, facilitators can ask about what
got in the way. For veterans who did, facilitators can ask whether they had any questions about the
material and how consistent the description of PTSD symptoms was with their own experiences.
II.

Problem identification

Facilitators then remind the group that the purpose of the TREC group is education and
treatment-planning, and that before treatment can be planned, goals for change must be identified.
Facilitators then remind the group that each of them identified one thing they would like to change
in session 1 and begin the discussion of problem identification by asking the group how they knew
that those things needed to be changed. This discussion can be guided into the broader topic of how
a person knows something is a problem. Facilitators should focus the discussion on interference in
important aspects of functioning (e.g., job, social activities, recreational activities, family/intimate
relationships, health) and distress as factors that indicate that a particular behavior is problematic.
Facilitators can note that people often engage in behaviors that cause difficulties because
those behaviors also bring about some desirable result. Any avoidance-related problem identified by
the group (e.g., isolation, drinking) can be used as an example of this. Facilitators can then ask
veterans whether there are any aspects of their lives that they are not sure are problematic. If
veterans have difficulty understanding this concept, facilitators can use as examples behaviors that
others think are problematic but with which the veteran is content, or behaviors that sometimes
yield good results and sometimes do not. The goal of this discussion is to guide the group toward
thinking of the positive aspects and costs of specific behaviors.
III.

Pro/con analysis

Facilitators then introduce the concept of pro/con or cost-benefit analysis to the group and
discuss its applicability to identify when a certain behavior is problematic. Facilitators emphasize
considering both the positive and negative consequences of the behavior to determine whether,
overall, the behavior is a problem and therefore whether the individual might benefit from changing
it. We use fear of snakes to illustrate this. An individual living in an old farmhouse in New England
may find that a fear of snakes causes significant distress and may be associated with avoidance, while
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bringing no positive consequences. Therefore, the individual may determine that the fear of snakes
as a problem that may be worth changing. An individual living in Hawai‘i would not have any
difficulties associated with anxiety or avoidance because there are no snakes in Hawai‘i, so for that
person the fear of snakes would not be problematic.
Facilitators should then demonstrate a pro/con analysis in the room, either by using an
example identified earlier by the group of something that might or might not be a problem or
soliciting the group for another example. Group members are invited to participate by discussing the
pros and cons of this example. Any avoidance-based behavior (e.g., social isolation, avoiding
confrontations, substance abuse) tends to work well because it allows facilitators to help the group
recognize that most of the positive aspects of avoidance (e.g., prevention or relief of distress) occur
in the short-term and most of the negative aspects are longer-term considerations.
IV.

Homework

Homework at the end of session 2 includes a worksheet to assist with identifying problems
one definitely has, problems one definitely does not have, problems that one is not sure one has, and
problems others say one has. Homework also includes a basic form for identifying pros and cons of
a potential problem. Both forms are taken from the Problem Area Review Group manual described
by Murphy et al. (2008). In addition, homework also includes a short-term and long-term pro/con
analysis form. Veterans are encouraged to spend time identifying aspects of their lives that they are
sure they want to change, aspects of their lives that they are sure they do not want to change, and
aspects of their lives about which they are ambivalent. For the aspects about which they are
ambivalent, they are encouraged to use pro/con analyses to try to determine whether that area is
problematic.
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Session 3 Contents
I.

Homework review

II.

Barriers to care

III.

Treatment options

IV.

Homework
I.

Homework review

As with session 2, facilitators begin session 3 by reviewing the homework and, for veterans
who did not complete the homework, asking what got in the way. For veterans who did the
homework, facilitators can ask whether they were able to resolve any aspects of their lives as
definitely or definitely not problems. Facilitators can ask the group whether anyone who did the
homework whether they would like to share it and can spend a few minutes discussing a specific
pro/con analysis. Alternately, facilitators can ask whether anyone had any difficulty determining
whether an aspect of their lives was a problem, and a pro/con analysis on that aspect can be
conducted as a group exercise.
II.

Barriers to care

Facilitators then open the discussion of barriers to care by asking veterans whether it was
easy or difficult to come into the VA at all, talk to a mental health provider, or come to the group. If
veterans report any degree of difficulty, facilitators can ask them why to draw out potential barriers
to care. We recommend listing these barriers on a board, and sorting them into categories (e.g.,
internal/external, logistical/emotional). We recommend that facilitators make sure that the
prospects of thinking about past events and/or experiencing unwanted emotions, stigma associated
with psychiatric diagnoses and treatment, beliefs about treatment and its efficacy, and logistical
barriers are discussed specifically.
We recommend that providers spend time expanding on the notion of stigma in two areas.
First, facilitators can ask the group what happened in the military if they disclosed or discussed pain
or distress. The discussion should be guided to the conclusion that though the military’s emphasis
on “soldiering on” despite pain or discomfort and maintaining focus on the mission is functional in
dangerous situations, it is very hard to sustain in the long-term and may be counter-productive when
dealing with mental health concerns.
Second, it is helpful for facilitators to note gender-specific norms in general American
culture for expressing distress or the need for help as a potential barrier to care. Examples can be
used from throughout the developmental trajectory to illustrate how others react when men
experience emotion (for example, how adults react when a four-year-old girl falls, skins a knee, and
cries versus when a four-year-old boy falls, skins a knee, and cries; athletes being praised for playing
through pain). If there are women in the group, we also recommend discussing the pressure on
women while they serve (if a male service member makes a mistake or cannot complete a task, he is
belittled, often with feminine labels, and if a female service member does the same thing, her and
other women’s abilities and right to serve are questioned) as an obstacle to disclosing distress.
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As mental health providers, we often forget how little the non-clinical population knows
about psychotherapy. We recommend that facilitators discuss different beliefs the group may have
about treatment. Veterans often have beliefs about negative things that therapy will do (e.g., “the
therapist will get inside my head,” “therapy will change my personality,” “I’ll start thinking about
it/feeling emotions and won’t stop”) or things that therapy will not change (e.g., “PTSD can’t be
treated,” “you’ll never make me forget it, so why bother?”).
Facilitators should then discuss ways to eliminate or get through the barriers. They can
initiate this discussion by asking group members how they have made it to three group sessions thus
far. For stigma-related concerns, facilitators can highlight the increased awareness of PTSD in
American culture. It can help to note that even though accounts of combatants returning from war
and suffering have been around for thousands of years, PTSD was not an actual diagnosis until
1980, and both scientific and lay understanding of PTSD has increased since then. Facilitators can
provide education to address beliefs about the potential effects, positive or negative, of treatment.
We recommend that facilitators address beliefs that diagnosis or treatment would result in loss of
government benefits, lower chances of employment, or restriction of access to firearms, regardless
of whether group members report them. Problem-solving can be used to address logistical
difficulties. Facilitators can ask the group how well it works to try to “soldier on” while symptoms of
PTSD are present. Overall, the focus should be on helping veterans decide whether the potential
gains of treatment can make the potential barriers worth dealing with.
III.

Treatment options

At this point, facilitators can summarize the group and note that the group has been
educated about PTSD, problems have been identified, and ways to address barriers have been
discussed. The next step is to talk about treatment options. How facilitators do this will depend
greatly on what options exist in the clinic at that time, and how those options are organized.
Currently, our clinic breaks options down into psychotherapy, pharmacotherapy, and research
treatments. The pros, cons, and evidence base for research treatments and pharmacotherapy are
described. Psychotherapy is broken down into four categories: supportive therapy, symptomfocused therapy, trauma-focused therapy, and complementary therapies. For each category, specific
options, structure (e.g., group or individual, duration), requirements (e.g., weekly attendance,
homework), potential outcomes (e.g., anger management group can help with responses when angry
but is unlikely to decrease re-experiencing symptoms), and evidence base are described. After
treatment options are presented, group members are given the opportunity to ask questions about
any of the material they have heard.
Our clinic has added specific education related to sleep treatments in the context of PTSD,
due to the high rates of insomnia and OSA in this population, and the risk of both untreated OSA
and insomnia rendering evidence-based PTSD treatments less effective. Again, what is provided in
this section may be determined by the available treatment options in your clinic or hospital. We have
chosen to strongly recommend that veterans with a positive score on the STOP Questionnaire be
referred to the sleep clinic to rule out OSA, and those with previously diagnosed OSA who are not
adequately compliant with OSA treatment (i.e., CPAP) be referred to the sleep clinic for CPAP
desensitization, or other methods of increasing compliance. For veterans with a diagnosis of
insomnia who do not have OSA, and those with a diagnosis of OSA who are compliant with
treatment, we recommend a referral to Cognitive Behavioral Therapy for Insomnia (CBT-I). We
engage in collaborative decision making with the veteran so that they can choose CBT-I or an EBP
for PTSD in either order or undertake both concurrently.
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It is helpful to emphasize during the discussion of treatment options that veterans may add
to or subtract from their treatment plan over time depending on the outcome of initial stages. For
example, a veteran who chooses to start with an anger management group because his anger causes
significant difficulty in interpersonal relationships may find that the group is helpful with anger but
does not change his self-blame or his sleep. At this point, the veteran may choose to try a course of
cognitive processing therapy or cognitive-behavioral therapy for insomnia.
IV.

Homework assignment

Homework at the end of session 3 includes a form on identifying barriers to care, which is
taken from the Problem Area Review Group manual described by Murphy et al. (2008). In addition,
group members are given materials on PTSD treatment in general (our clinic uses the document on
treatment found on the website of the National Center for PTSD, www.ptsd.va.gov) as well as
specific treatments available in the treatment program. Our clinic provides a schematic of research,
medication, and therapy options as well as our brochure of group therapy offerings. Group
members are instructed to read the materials over and identify options that they think might be best
for them at this time. They may also be given a form to write down their ideas.
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Session 4 Contents

I.

I.

Homework review

II.

Treatment planning

III.

Wrap-up
Homework review

As with sessions 2 and 3, facilitators begin session 4 by reviewing the homework and, for
veterans who did not complete the homework, asking what got in the way. For veterans who did,
facilitators can ask whether they discovered any barriers to care that affect them more than others.
Ways to move past these barriers should be identified. Facilitators should also solicit and respond to
any questions about treatment or specific treatment options.
II.

Treatment planning

Facilitators should provide a complete review of the options discussed in session 3 and
provide group members with ample time to ask questions or express concerns. At this point in the
group, members choose their next steps in treatment. Facilitators should emphasize that there is no
right or wrong place to begin the treatment process, and the initial plan may be all the group
member needs or may be the first step in a progression of care. Facilitators then ask group members
whether they have decided what they might like to do as their next step in treatment. Any group
members who have decided what they would like can report their treatment options. Facilitators will
write these choices down on the treatment-plan form.
Group members who are not certain are given the opportunity to discuss any concerns they
might have about treatment options they are considering. Typically, group members ask whether
they can engage in more than one treatment at the same time, or whether there is an optimal order
of treatment. Group members may also ask which treatments are best for specific symptoms (e.g.,
nightmares). Responses to these questions will depend on the specific treatment options being
offered in the clinic at that time as well as the clinic’s philosophy on engaging in more than one
treatment at once.
The disposition of group members who are unable to select a treatment plan, or who do not
want to engage in any of the treatments offered, will vary according to the organization of the clinic.
In our clinic at this time, group members who do not select a treatment plan are referred back to the
referring provider in order to complete the treatment-planning process.
Though treatment-planning is completed in the group, we recommend that facilitators
familiarize themselves with the basic backgrounds and trauma histories of group members. If there
are group members whose histories may make it difficult for them to talk about treatment concerns
in front of others (e.g., veterans with history of military sexual trauma who might want to join an
MST support group), facilitators may consider giving group members the option of talking over
options with them after the session is over.
Each group member is provided with a written summary of his or her plan. This summary
also contains the contact information for the group facilitators, who function as points of contact
until the group member begins his or her next step in treatment.
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III.

Wrap-up

Once treatment plans are developed for each group member, the group curriculum is
complete. Group members are congratulated for completing the group. At this time, facilitators
summarize the progress of the group, and provide general encouragement about the prospects of
treatment for PTSD and related symptoms. Facilitators also solicit feedback from group members
about what aspects of the group were helpful and which ones were not as helpful. If appropriate,
facilitators may also note that though some group members may have had concerns about
participating in a group, they were able to tolerate the treatment and complete all the requirements.
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GUIDE TO FORMS
The following forms are provided to group members. The source for forms not appearing in
this manual is given.
Session 1
What is PTSD?
(taken from www.ptsd.va.gov)
Avoidance
(taken from www.ptsd.va.gov)
Sleep Problems and PTSD
(taken from www.ptsd.va.gov/understand/related/sleep_problems.asp)
Session 2
Problem identification worksheet
Pros and cons worksheet
Short-term and long-term pros and cons worksheet
Session 3
Roadblocks to change worksheet
Clinic treatment options (“do something/do nothing”)
Clinic group therapy brochure
PTSD Treatment
(taken from www.ptsd.va.gov)
Session 4
Treatment plan
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PROBLEM IDENTIFICATION
Problems You
DEFINITELY
HAVE

MIGHT HAVES
Problems you
Problems you
might have: You
might have:
have wondered if
Problems other
you have
people say you
have but you
disagree

Problems You
DEFINITELY
DON’T HAVE

From Problem Area Group patient workbook (Murphy et al., 2009).
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PROs & CONs
Behavior:____________________________________
Pros (Benefits) to ________
Cons (Disadvantages) to ________

From Problem Area Group patient workbook (Murphy et al., 2009).
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Short-Term
Positive

Long-Term
Negative

If I continue to…

If I stop and change and
start to…
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Positive

Negative
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ROADBLOCKS TO CHANGE
When you think of your personal roadblocks, ask yourself what the roadblocks to change would be
for a veteran or any other person. We all can think of many reasons why we shouldn’t change. But
now we want you to think about what’s behind the fear of change.
LIST OF ROADBLOCKS
This is a list of thoughts, feelings, and beliefs that might prevent someone from taking an honest
look at themselves. Some may apply to you, and some may not.
Fears

Feelings

Fear of rejection

Guilt

Fear of change

Shame

Fear of embarrassment
Fear of feeling “weak”
Fear of being seen as weak

Beliefs

Fear of feeling overwhelmed

Admitting a problem equals weakness

Fear of emotions coming up

Shameful to tell other people your problems

Fear of facing truth

Don’t deserve help

Fear of crying

Shame about past events

Fear of not being able to stop crying

Don’t want to think about past events

Fear of “I told you so”

Don’t want to have feelings of failure

Fear of finding out I’m “crazy”

Don’t want to fail

Fear that others will think I’m crazy

Have to take care of problems yourself

Fear of being “locked up”
Fear of being judged

Internal Stereotypes

Fear of being seen as “damaged”

Belief that alcohol problem = “skid row”

Fear of feeling “stupid”

type of alcoholic, homeless

Fear that others will see me as “stupid”

Belief that drug problem = dirty “addict”

Fear of losing control

Belief that needing help for psychological
problems = “crazy mental patient”
From Problem Area Group patient workbook (Murphy et al., 2009).
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MY ROADBLOCKS
List Your Own "Roadblocks" to Accepting That You
May Have Additional Problems:
•

•

•

•

Fears:

.
.
.
.
.
.

Distortions:

.
.
.
.
.
.

Stereotypes:

.
.
.
.
.

Other:

.
.
.
.
.
.

From Problem Area Group patient workbook (Murphy et al., 2009).
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OUTPATIENT PTSD CLINIC TREATMENT OPTIONS
The PTSD program at this VA offers a variety of treatments to help veterans with PTSD improve
their lives. Each veteran works with treatment providers to determine his or her treatment plan,
based on what he or she wants to change and is willing to do. We offer the following options:

Medication
—Can be effective at reducing
overall PTSD symptoms and/or
targeting specific aspects of PTSD
(e.g., insomnia or depression).
—Work with provider to identify
target symptoms and medication
options.
—Potential side effects.
—May need adjustments to find
most effective medication(s) with
least side effects.
—Can be done in conjunction
with therapy.

Psychotherapy
—Can be effective at decreasing
symptoms and targeting specific
aspects of PTSD (like sleep or
depression).
—Significant time commitment
—The more trauma-focused and
intensive the therapy, the more
effective it is likely to be.
—There are several different
types of therapy available…

Trauma-focused therapy
Trauma-focused therapies are the
most effective PTSD treatments.
They target the traumatic event
or events directly. These
therapies focus on engaging with
the trauma memory and
examining emotions and beliefs
related to trauma. They are very
structured and intense with
frequent homework.
• Prolonged exposure (PE)
• Cognitive processing therapy
(CPT)

Symptom-focused therapy
Treatments targeting specific
PTSD symptoms or
problems. These are more
structured and often include
homework. We offer
symptom-focused groups
and some individual services
in the following areas:
• Anger management
• Sleep (CBT-Insomnia)
• Substance use problems
• Parenting skills
• Emotion regulation
• Anxiety skills group
• Relaxation/stress
management

Research
—Participation in research is
completely voluntary.
—The VA Healthcare
System and the National
Center for PTSD conduct
research to learn more about
PTSD.
—Some of the research
involves medications or
therapies.
—Times are flexible and
some studies pay you to
participate.
—You can stop participating
at any time.
Supportive therapy
Groups of veterans with similar
histories or concerns meet to
support each other. Supportive
therapy involves a lower intensity
level and less work outside of
session. Research indicates it may
not decrease symptoms, but many
veterans find it helpful and
meaningful.
• OEF/OIF Readjustment
Group
• Military sexual trauma groups
• Substance use groups

Complementary Therapies
Focus on increasing positive aspects of a person’s life by mobilizing strengths, initiative, and creativity through
expressive and mindfulness-related therapies. They can provide support, reduce stress, improve mood and focus,
access and express thoughts and feelings, foster insight, increase self-awareness, and decrease isolation. These therapies
offer a means to cope, enhance resilience, and provide a sense of accomplishment, fulfillment, and meaning.
• Art therapy • Music therapy • Mindful yoga • Adapted sports • Transcendental meditation
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CONGRATULATIONS!

You have completed the PTSD/Anxiety Clinic’s Trauma Recovery Education Class.

Your next step is:

If you have any questions about this plan, please contact ENTER FACILITATOR NAMES HERE.
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Appendix J
Patient Tracking and Protocol Fidelity Form for TREC Implementation
Veteran ID: _______________________________

TREC Cohort:_______________________________

1. Does the veteran have an existing diagnosis of sleep apnea (based on chart review)?
Yes

No

2. Is the veteran compliant with sleep apnea treatment (based on veteran self-report or chart review)?
Yes

No

3. Was the Veteran sent a STOP Questionnaire?
Yes

No

4. Did the veteran return the STOP Questionnaire?
Yes

No

If YES, score:

5. Did the veteran score positive on the STOP (answered “YES” to 2 or more questions)?
Yes

No

6. If the answer to #5 is “YES,” was the following recommendation provided to the MHTC within TREC progress note or
addendum?
“This Veteran completed a STOP Questionnaire for sleep apnea and answered “YES” to 2 or more questions, indicating
that the veteran has a high risk of Obstructive Sleep Apnea. It is recommended that a consult for a sleep study be placed
(“Sleep Testing”).”
Yes

No

7. Was the veteran sent an ISI?
Yes

No

8. Did the veteran return the ISI?
Yes

No

If YES, score:

9. Did the veteran score positive on the ISI (score of “8” or above)?
Yes

No

10. If the answer to #9 is “YES,” was the following recommendation provided to the MHTC within TREC progress note or
addendum?
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“This Veteran completed an Insomnia Severity Index and scored in the positive range, indicating subthreshold or clinical
insomnia. It is recommended that a sleep assessment be performed by the MHTC or the sleep clinic and, if appropriate, a
referral to CBT for Insomnia be placed (“CBTI Consult Outpt”).”
Yes

No

11. Veteran attended the following sessions of TREC and received the following education:
12.
a.

Session 1

Attended: _____________
Educated about the co-morbidities of insomnia and OSA, with basic definitions provided: _____________
Received patient education material about PTSD and sleep: _____________

b.

Session 2

Attended: _____________
Session 1 Information reviewed: _____________

c.

Session 3

Attended: ____________
Received education about recommended treatments for OSA: _____________
Received education about recommended treatments for insomnia: _____________

d.

Session 4

Attended: _____________
Treatment plan is in line with recommendations: _____________

13. Did the Veteran receive an electronic referral to the Sleep Clinic within 60 days following the TREC Cohort?
Yes

No

14. Did the Veteran receive an electronic referral to CBT-I within 60 days following the TREC Cohort?
Yes

No
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Appendix K
Patient Education Material for TREC
Sleep Problems & PTSD
Taken from: https://www.ptsd.va.gov/understand/related/sleep_problems.asp
*please see website for helpful patient videos
Almost everyone with PTSD reports sleep problems. In fact, trouble sleeping is the main reason that people first go to a
doctor to get help for PTSD. Both insomnia—trouble falling or staying asleep—and nightmares are PTSD symptoms. The
good news is there are evidence-based treatments that can help with PTSD and sleep problems. And, these treatments
help whether your sleep problems began before a traumatic event or only came about after the trauma.
Why Is Sleep Important?
Both how well (quality) and how much (quantity) a person sleeps are important.
Poor sleep may lead to:
• Slow reaction time
• Trouble with learning and memory
• Feeling irritable and mood problems
• Trouble with thinking and concentration
• Thinking about suicide or acting in ways that self-harm
• Also, sleep problems that last a long time are related to medical problems such as heart disease, depression,
kidney disease, high blood pressure, diabetes, obesity and stroke.
How Does PTSD Affect Sleep?
Both nightmares and insomnia are symptoms of PTSD. Nightmares are often a replay of the traumatic event; and, if the
dreams cause kicking and screaming, bed partners can be affected too. Nightmares can also make it difficult to fall back
asleep. Insomnia is when a person has trouble falling or staying asleep at least three nights a week. This lack of sleep
continues for a few months or more and is severe enough to cause problems at work and at home.
Because people with PTSD may try to push away trauma memories during the day, it may cause worries to get worse at
night and disrupt sleep. Here are some examples:
Avoidance. People with PTSD may avoid going to sleep. Nightmares and flashbacks—feeling like the trauma is
happening again—can create fear or feeling as if going to bed is unsafe.
Loss of sleep time. Whether or not insomnia is diagnosed, people with PTSD often report less sleep due to problems
falling asleep, being restless during the night and waking up earlier than wanted. Even brief periods of sleep loss can
affect daily life.
Increased arm and leg movement. After a trauma, people may have more arm and leg movements during sleep. This
can make someone feel restless.
Talking during sleep. After a trauma, people may talk more in their sleep. Talking during sleep can affect bed partners.
Feeling "on alert." People with PTSD may feel the need to be on guard, to protect themselves from danger. It is difficult
to have restful sleep when you feel the need to be always alert or are startled easily by noise.
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Not liking silence. Some may be uneasy with silence after a trauma. When this happens, a person may keep a television
on all night. Changes in light and sound can disrupt the deepest and most needed level of sleep.
What Is the Relationship Between PTSD, Sleep Problems and Substance Use?
Sleep problems may become their own disorders that cause distress. As a result, some will use substances such as
alcohol, marijuana, or other drugs to fall asleep. Over time, drug and alcohol use can also have negative effects on sleep
quality and on overall health and functioning.
What Is the Best Treatment for Sleep Problems?
The best treatment for insomnia is Cognitive Behavioral Therapy for Insomnia, or CBT-I. This talk therapy is
recommended over medication because it is more effective—CBT-I has been shown to work in multiple research
studies—and has fewer side effects than medication. CBT-I improves sleep in 7 out of 10 people who complete it.
Research also shows that CBT-I reduces how many nightmares people have and the distress related to upsetting dreams.
How does CBT-I work?
CBT-I focuses on a person's beliefs, feelings, and behaviors that affect sleep. A trained CBT-I therapist may offer the
treatment in one-on-one appointments or to a group of people with insomnia. It usually lasts six sessions. CBT-I can be
delivered in person or through video medical appointments. There are also online programs and a smartphone app—
CBT-I Coach—designed to help with the treatment.
What is “sleep hygiene” Is it the same as CBT-I?
Sleep hygiene includes various practices and habits that are important for good sleep. It includes tips to change
behaviors that may interfere with sleep. For example, you may limit beverages with caffeine before bedtime to fall
asleep more easily. Or, you may find that you need to adjust your sleep environment—such as limiting smartphone use
or television viewing in bed—to be more comfortable. CBT-I, on the other hand, is a more focused treatment for chronic
insomnia. Sleep hygiene is not the same as CBT-I treatment, but it is often included as a part of CBT-I.
What are the pros and cons of using sleep medication?
Sleep medication is easy to take and usually provides quick, temporary relief. There are many different types of
medications used for sleep, from herbal supplements and over-the-counter sleep aids to prescription medications. If you
choose to take medication, you should be familiar with the side effects and risks before you take it.
Sleep medication side effects usually include daytime drowsiness, dizziness and confusion. Sleep medication is often
recommended for short-term use only (2 to 4 weeks). These medications usually become less helpful over time and
don't get to the core cause of sleep problems.
Certain prescription sleep medication can cause serious side effects with long-term use. Examples include:
Benzodiazepines: such as Xanax, Klonopin, Valium or Ativan
Nonbenzodiazepines (or "Z-drugs"): such as Ambien, Lunesta and Sonata
Although benzodiazepines—or "benzos"—can make people feel calm, relaxed or sleepy, they can become a problem in
the long run and are not recommended for the treatment of PTSD.
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Compare Your Treatment Options:

What Other Sleep Problems Affect People with PTSD?
Sleep apnea is common among people with PTSD, particularly in Veterans. Sleep apnea is a breathing problem that
disrupts normal sleep. People with sleep apnea may wake up not feeling rested and struggle with feeling tired or
needing to sleep during the daytime.
Being aware of sleep apnea can be difficult. There are many causes of fatigue or feeling tired during the day. Also, with
sleep apnea, breathing pauses (or disruptions) happen during sleep, so a person may be unaware of those symptoms.
Often a bed partner notices those breathing changes or snoring first.
To diagnose sleep apnea, a provider may recommend a sleep study. Treatment can include lifestyle changes and use of a
breathing device—continuous positive airway pressure, or CPAP machine—at night. Research suggests that for those
with PTSD and sleep apnea, using a CPAP device may benefit PTSD treatment.
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Final Points About PTSD and Sleep
With PTSD, it can take some time and effort to get good sleep. Using marijuana, alcohol and street drugs to manage
PTSD or sleep problems is related to a higher risk of thoughts about suicide and suicide attempts. There are effective
treatments available for sleep problems and PTSD. Work with your provider to learn about your treatment options and
decide on the best fit for your needs.
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Appendix L
VACHS IRB Exemption
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Appendix M
Timeline
Milestone
Adapt evidenced-based protocol for veterans with PTSD and
sleep disturbance
Establish implementation team
Finalize implementation team meeting schedule and
communication plan
Revise TREC curriculum and procedures
Train TREC facilitators in new manual process
Implement adapted protocol in TREC
Data collection/analysis
Permanently adapt new TREC procedure and curriculum
Report outcomes to PTSD Clinic
Submit abstracts to APNA Conference, and a peer reviewed
journal for dissemination and potential publication
Expand protocol to individual evaluations and treatment planning
in West Haven VA PTSD Clinic and other PTSD clinics
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Projected Dates
8/1/2021-9/30/2021
9/1/2021-9/15/2021
9/15/2021-9/30/2021
8/1/2021-9/15/2021
9/15/2021-9/30/2021
10/1/2021-11/30/2021
11/20/20/202112/31/2021
1/2/2022-1/31/2022
4/1/2022-4/30/2022
4/1/2022-4/30/22
5/1/2022-8/1/2022

Appendix N
Project Expense Budget

Program Expense
Salaries/wages (Admin support,
practitioners, statistics
consultant)
No additional costs

Projected Cost

Actual Cost

$0

$0

Hard copy of screening measures
(STOP & ISI) for each TREC
group attendee

$1.60

$1.60

Hard copy of patient education
material for each TREC attendee

$4.00

$4.00

Postage & return postage for each
TREC group attendee

$23.20

$23.20

Tracking sheet for each TREC
group attendee

$2.00

$2.00

Poster purchase/printing for
conferences
Capital costs (hardware,
equipment)

$100

$100

No additional costs

$0

$0

$0

$0

Thank you breakfast for
implementation team, PTSD
clinicians and director

$150

$150

Total Project Expenses

$280.80

$280.80

Start-up costs (copies, charts,
displays, etc.)

Operational costs
(heat/electricity)
No additional costs
Other
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